One	O
base	O
pair	O
change	O
abolishes	O
the	O
T	O
cell-restricted	O
activity	O
of	O
a	O
kB-like	B-DNA
proto-enhancer	I-DNA
element	I-DNA
from	O
the	O
interleukin	B-DNA
2	I-DNA
promoter	I-DNA
.	O

The	O
inducible	O
,	O
T	B-DNA
cell-specific	I-DNA
enhancers	I-DNA
of	O
murine	B-DNA
and	I-DNA
human	I-DNA
Interleukin	I-DNA
2	I-DNA
(	I-DNA
Il-2	I-DNA
)	I-DNA
genes	I-DNA
contain	O
the	O
kB-like	B-DNA
sequence	I-DNA
GGGATTTCACC	O
as	O
an	O
essential	B-DNA
cis-acting	I-DNA
enhancer	I-DNA
motif	I-DNA
.	O

When	O
cloned	O
in	O
multiple	O
copies	O
this	O
so-called	O
TCEd	B-DNA
(	O
distal	B-DNA
T	I-DNA
cell	I-DNA
element	I-DNA
)	O
acts	O
as	O
an	O
inducible	O
proto-enhancer	B-DNA
element	I-DNA
in	O
E14	B-cell_line
T	I-cell_line
lymphoma	I-cell_line
cells	I-cell_line
,	O
but	O
not	O
in	O
HeLa	B-cell_line
cells	I-cell_line
.	O

In	O
extracts	O
of	O
induced	O
,	O
Il-2	B-cell_line
secreting	I-cell_line
El4	I-cell_line
cells	I-cell_line
three	O
individual	O
protein	B-protein
factors	I-protein
bind	O
to	O
TCEd	B-DNA
DNA	I-DNA
.	O

The	O
binding	O
of	O
the	O
most	O
prominent	O
factor	O
,	O
named	O
TCF-1	B-protein
(	O
T	B-protein
cell	I-protein
factor	I-protein
1	I-protein
)	O
,	O
is	O
correlated	O
with	O
the	O
proto-enhancer	O
activity	O
of	O
TCEd	O
.	O

TCF-1	B-protein
consists	O
of	O
two	O
polypeptides	O
of	O
about	O
50	O
kD	O
and	O
105	O
kD	O
;	O
the	O
former	O
seems	O
to	O
be	O
related	O
to	O
the	O
50	B-protein
kD	I-protein
polypeptide	I-protein
of	O
NF-kB	B-protein
.	O

Purified	B-protein
NF-kB	I-protein
is	O
also	O
able	O
to	O
bind	O
to	O
the	O
TCEd	B-DNA
,	O
but	O
TCF-1	B-protein
binds	O
stronger	O
than	O
NF-kB	B-protein
to	O
TCEd	B-DNA
DNA	O
.	O

The	O
conversion	O
of	O
the	O
TCEd	B-DNA
to	O
a	O
'perfect	B-DNA
'	I-DNA
NF-kB	I-DNA
binding	I-DNA
site	I-DNA
leads	O
to	O
a	O
tighter	O
binding	O
of	O
NF-kB	B-protein
to	O
TCEd	B-DNA
DNA	I-DNA
and	O
,	O
as	O
a	O
functional	O
consequence	O
,	O
to	O
the	O
activity	O
of	O
the	O
'converted	B-DNA
'	I-DNA
TCEd	I-DNA
motifs	I-DNA
in	O
HeLa	B-cell_line
cells	I-cell_line
.	O

Thus	O
,	O
the	O
substitution	O
of	O
the	O
underlined	O
A	O
residue	O
to	O
a	O
C	O
within	O
the	O
GGGATTTCACC	B-DNA
motif	I-DNA
abolishes	O
its	O
T	O
cell-restricted	O
activity	O
and	O
leads	O
to	O
its	O
functioning	O
in	O
both	O
El4	B-cell_line
cells	I-cell_line
and	O
HeLa	B-cell_line
cells	I-cell_line
.	O

These	O
results	O
indicate	O
that	O
lymphocyte-specific	O
factors	O
binding	O
to	O
the	O
TCEd	B-DNA
are	O
involved	O
in	O
the	O
control	O
of	O
T	O
cell	O
specific-transcription	O
of	O
the	O
Il-2	B-DNA
gene	I-DNA
.	O

Â©	NULL
1991	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
5929-5936	NULL
One	NULL
base	NULL
pair	NULL
change	NULL
abolishes	NULL
the	NULL
T	NULL
cell-restricted	NULL
activity	NULL
of	NULL
a	NULL
kB-like	NULL
proto-enhancer	NULL
element	NULL
from	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
Karoline	NULL
Briegel*	NULL
,	NULL
Bernd	NULL
Hentsch	NULL
,	NULL
Isolde	NULL
Pfeuffer	NULL
and	NULL
Edgar	NULL
Serfling*	NULL
Institut	NULL
fur	NULL
Virologie	NULL
und	NULL
Immunbiologie	NULL
der	NULL
Universitat	NULL
Wurzburg	NULL
,	NULL
Versbacher	NULL
StraBe	NULL
7	NULL
,	NULL
D-87	NULL
Wurzburg	NULL
,	NULL
FRG	NULL
Received	NULL
July	NULL
25	NULL
,	NULL
1991	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
October	NULL
7	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
The	NULL
inducible	NULL
,	NULL
T	NULL
cell-specific	NULL
enhancers	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
Interleukin	NULL
2	NULL
(	NULL
II-2	NULL
)	NULL
genes	NULL
contain	NULL
the	NULL
kB-like	NULL
sequence	NULL
GGGATTTCACC	NULL
as	NULL
an	NULL
essential	NULL
cis-acting	NULL
enhancer	NULL
motif	NULL
.	NULL

When	NULL
cloned	NULL
in	NULL
multiple	NULL
copies	NULL
this	NULL
so-called	NULL
TCEd	NULL
(	NULL
distal	NULL
T	NULL
cell	NULL
element	NULL
)	NULL
acts	NULL
as	NULL
an	NULL
inducible	NULL
proto-enhancer	NULL
element	NULL
in	NULL
El4	NULL
T	NULL
lymphoma	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
extracts	NULL
of	NULL
induced	NULL
,	NULL
II-2	NULL
secreting	NULL
E14	NULL
cells	NULL
three	NULL
individual	NULL
protein	NULL
factors	NULL
bind	NULL
to	NULL
TCEd	NULL
DNA	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
most	NULL
prominent	NULL
factor	NULL
,	NULL
named	NULL
TCF-1	NULL
(	NULL
T	NULL
cell	NULL
factor	NULL
1	NULL
)	NULL
,	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
TCEd	NULL
.	NULL

TCF-1	NULL
consists	NULL
of	NULL
two	NULL
polypeptides	NULL
of	NULL
about	NULL
50kD	NULL
and	NULL
105kD	NULL
;	NULL
the	NULL
former	NULL
seems	NULL
to	NULL
be	NULL
related	NULL
to	NULL
the	NULL
50kD	NULL
polypeptide	NULL
of	NULL
NF-kB	NULL
.	NULL

Purified	NULL
NF-kB	NULL
is	NULL
also	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
TCEd	NULL
,	NULL
but	NULL
TCF-1	NULL
binds	NULL
stronger	NULL
than	NULL
NF-kB	NULL
to	NULL
TCEd	NULL
DNA	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
the	NULL
TCEd	NULL
to	NULL
a	NULL
'perfect	NULL
'	NULL
NF-kB	NULL
binding	NULL
site	NULL
leads	NULL
to	NULL
a	NULL
tighter	NULL
binding	NULL
of	NULL
NF-kB	NULL
to	NULL
TCEd	NULL
DNA	NULL
and	NULL
,	NULL
as	NULL
a	NULL
functional	NULL
consequence	NULL
,	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
'converted	NULL
'	NULL
TCEd	NULL
motifs	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
substitution	NULL
of	NULL
the	NULL
underlined	NULL
A	NULL
residue	NULL
to	NULL
a	NULL
C	NULL
within	NULL
the	NULL
GGGATTTCACC	NULL
motif	NULL
abolishes	NULL
its	NULL
T	NULL
cell-restricted	NULL
activity	NULL
and	NULL
leads	NULL
to	NULL
its	NULL
functioning	NULL
in	NULL
both	NULL
El4	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
lymphocyte-specific	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
TCEd	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
T	NULL
cell	NULL
specific-transcription	NULL
of	NULL
the	NULL
II-2	NULL
gene	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
expression	NULL
of	NULL
tissue-specific	NULL
genes	NULL
is	NULL
controlled	NULL
to	NULL
a	NULL
large	NULL
extent	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
by	NULL
the	NULL
activity	NULL
of	NULL
tissue-specific	NULL
promoters	NULL
and	NULL
enhancers	NULL
.	NULL

These	NULL
control	NULL
elements	NULL
consist	NULL
of	NULL
multiple	NULL
sequence	NULL
motifs	NULL
that	NULL
are	NULL
bound	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
transacting	NULL
factors	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
enhancers	NULL
of	NULL
many	NULL
tissue-specific	NULL
genes	NULL
,	NULL
for	NULL
example	NULL
those	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
,	NULL
globin	NULL
and	NULL
albumin	NULL
genes	NULL
,	NULL
interact	NULL
with	NULL
cell	NULL
type-specific	NULL
factors	NULL
as	NULL
well	NULL
as	NULL
ubiquitous	NULL
factors	NULL
,	NULL
and	NULL
it	NULL
is	NULL
assumed	NULL
that	NULL
the	NULL
cooperative	NULL
activity	NULL
of	NULL
both	NULL
types	NULL
of	NULL
factors	NULL
controls	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
linked	NULL
gene	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
immunoglobulin	NULL
enhancers	NULL
,	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
Interleukin	NULL
2	NULL
(	NULL
I1-2	NULL
)	NULL
enhancer	NULL
is	NULL
restricted	NULL
to	NULL
one	NULL
cell	NULL
type	NULL
,	NULL
i.e	NULL
.	NULL

to	NULL
T	NULL
lymphocytes	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
II-2	NULL
enhancer	NULL
harbors	NULL
several	NULL
T	NULL
cell-specific	NULL
proto-enhancer	NULL
elements	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

These	NULL
are	NULL
protein	NULL
binding	NULL
sites	NULL
which	NULL
exert	NULL
a	NULL
T	NULL
cell-specific	NULL
activity	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
when	NULL
they	NULL
are	NULL
cloned	NULL
in	NULL
multiple	NULL
copies	NULL
in	NULL
front	NULL
of	NULL
a	NULL
test	NULL
gene	NULL
.	NULL

One	NULL
of	NULL
the	NULL
T	NULL
cell-specific	NULL
II-2	NULL
proto-enhancer	NULL
elements	NULL
,	NULL
the	NULL
so-called	NULL
distal	NULL
T	NULL
cell	NULL
element	NULL
(	NULL
TCEd	NULL
)	NULL
(	NULL
4	NULL
)	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
to	NULL
bind	NULL
in	NULL
vitro	NULL
the	NULL
ubiquitous	NULL
factor	NULL
NF-kB	NULL
as	NULL
well	NULL
as	NULL
lymphocyte-specific	NULL
factors	NULL
(	NULL
4	NULL
,	NULL
6-9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
so	NULL
far	NULL
there	NULL
is	NULL
no	NULL
compelling	NULL
experimental	NULL
evidence	NULL
on	NULL
how	NULL
the	NULL
binding	NULL
of	NULL
these	NULL
factors	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
establishment	NULL
of	NULL
T	NULL
cell-retricted	NULL
activity	NULL
of	NULL
the	NULL
TCEd	NULL
motif	NULL
in	NULL
vivo	NULL
.	NULL

NF-kB	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
lymphocyte	NULL
restricted	NULL
transcription	NULL
factor	NULL
,	NULL
but	NULL
soon	NULL
it	NULL
was	NULL
also	NULL
found	NULL
in	NULL
an	NULL
inducible	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
non-lymphoid	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Active	NULL
ubiquitous	NULL
NF-kB	NULL
consists	NULL
of	NULL
two	NULL
components	NULL
,	NULL
i.e	NULL
.	NULL

of	NULL
polypeptides	NULL
of	NULL
about	NULL
50	NULL
kD	NULL
and	NULL
65kD	NULL
which	NULL
share	NULL
sequence	NULL
similarity	NULL
with	NULL
the	NULL
products	NULL
of	NULL
proto-oncogene	NULL
c-rel	NULL
,	NULL
the	NULL
oncogene	NULL
v-rel	NULL
and	NULL
the	NULL
Drosophila	NULL
gene	NULL
dorsal	NULL
(	NULL
12-15	NULL
)	NULL
.	NULL

The	NULL
65kD	NULL
polypeptide	NULL
seems	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
NF-kB	NULL
with	NULL
IkB	NULL
,	NULL
the	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
(	NULL
16	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
IKB	NULL
is	NULL
the	NULL
primary	NULL
target	NULL
for	NULL
the	NULL
numerous	NULL
extracellular	NULL
signals	NULL
which	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
are	NULL
part	NULL
of	NULL
transcriptional	NULL
control	NULL
regions	NULL
of	NULL
numerous	NULL
cytokine	NULL
and	NULL
lymphokine	NULL
genes	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
inducibility	NULL
of	NULL
NF-kB	NULL
by	NULL
stimuli	NULL
which	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
resting	NULL
T	NULL
lymphocytes	NULL
led	NULL
to	NULL
the	NULL
assumption	NULL
that	NULL
NF-kB	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
many	NULL
lymphokine	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
I1-2	NULL
gene	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
many	NULL
of	NULL
the	NULL
kB-like	NULL
sequence	NULL
elements	NULL
of	NULL
lymphokine	NULL
gene	NULL
enhancers	NULL
and	NULL
promoters	NULL
diverge	NULL
in	NULL
their	NULL
primary	NULL
structure	NULL
from	NULL
the	NULL
'consensus	NULL
'	NULL
NF-kB	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
they	NULL
represent	NULL
only	NULL
weak	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
shown	NULL
whether	NULL
the	NULL
weak	NULL
binding	NULL
of	NULL
NF-kB	NULL
to	NULL
these	NULL
kB-like	NULL
elements	NULL
in	NULL
vitro	NULL
has	NULL
any	NULL
functional	NULL
implication	NULL
for	NULL
the	NULL
control	NULL
of	NULL
lymphokine	NULL
gene	NULL
activities	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
TCEd	NULL
sequence	NULL
differs	NULL
in	NULL
a	NULL
few	NULL
nucleotides	NULL
from	NULL
a	NULL
canonical	NULL
NF-kB	NULL
binding	NULL
site	NULL
.	NULL

We	NULL
will	NULL
show	NULL
in	NULL
this	NULL
study	NULL
that	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
+	NULL
Present	NULL
address	NULL
:	NULL
Institut	NULL
fiir	NULL
Molekulare	NULL
Pathologie	NULL
,	NULL
Dr	NULL
Bohr-Gasse	NULL
7	NULL
,	NULL
A-1030	NULL
Vienna	NULL
,	NULL
Austria	NULL
5930	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
in	NULL
extracts	NULL
of	NULL
activated	NULL
E14	NULL
T	NULL
lymphoma	NULL
cells	NULL
three	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
TCEd	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
most	NULL
prominent	NULL
factor	NULL
,	NULL
named	NULL
TCF-1	NULL
,	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
TCEd	NULL
in	NULL
E14	NULL
cells	NULL
.	NULL

TCF-1	NULL
consists	NULL
of	NULL
two	NULL
polypeptides	NULL
of	NULL
about	NULL
105kD	NULL
and	NULL
S5SOkD	NULL
;	NULL
the	NULL
latter	NULL
seems	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
the	NULL
SOkD	NULL
polypeptide	NULL
of	NULL
NF-kB	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
will	NULL
show	NULL
that	NULL
the	NULL
transition	NULL
of	NULL
the	NULL
underlined	NULL
A	NULL
residue	NULL
within	NULL
the	NULL
TCEd	NULL
'core	NULL
'	NULL
sequence	NULL
,	NULL
GGG-ATTTCACC	NULL
,	NULL
to	NULL
a	NULL
C	NULL
converts	NULL
this	NULL
weak	NULL
NF-kB	NULL
binding	NULL
site	NULL
to	NULL
a	NULL
distinctly	NULL
stronger	NULL
NF-kB	NULL
binding	NULL
site	NULL
and	NULL
abolishes	NULL
its	NULL
T	NULL
cell-restricted	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
change	NULL
of	NULL
one	NULL
nucleotide	NULL
determines	NULL
whether	NULL
this	NULL
kB-like	NULL
proto-enhancer	NULL
motif	NULL
acts	NULL
as	NULL
a	NULL
cell	NULL
type-specific	NULL
or	NULL
ubiquitous	NULL
enhancer	NULL
motif	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
line	NULL
with	NULL
the	NULL
conclusion	NULL
that	NULL
in	NULL
T	NULL
lymphocytes	NULL
the	NULL
activity	NULL
of	NULL
kB-like	NULL
enhancer	NULL
motifs	NULL
of	NULL
lymphokine	NULL
genes	NULL
is	NULL
controled	NULL
by	NULL
several	NULL
differently	NULL
regulated	NULL
DNA	NULL
binding	NULL
proteins	NULL
(	NULL
see	NULL
ref	NULL
.	NULL

18	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
,	NULL
DNA	NULL
transfections	NULL
and	NULL
CAT	NULL
assays	NULL
Murine	NULL
E4	NULL
lymphoma	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
to	NULL
a	NULL
density	NULL
of	NULL
about	NULL
4x	NULL
10Â°	NULL
cells	NULL
per	NULL
mi	NULL
.	NULL

1.6	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
DNA	NULL
(	NULL
purified	NULL
by	NULL
two	NULL
CsCl/ethidium	NULL
bromide	NULL
density	NULL
gradient	NULL
centrifugations	NULL
)	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
1.2	NULL
ml	NULL
using	NULL
the	NULL
DEAE	NULL
dextran	NULL
procedure	NULL
(	NULL
19	NULL
)	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
shocked	NULL
with	NULL
15	NULL
%	NULL
dimethylsulfoxide	NULL
for	NULL
3	NULL
min	NULL
and	NULL
,	NULL
20	NULL
hr	NULL
later	NULL
,	NULL
they	NULL
were	NULL
divided	NULL
.	NULL

One	NULL
half	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
the	NULL
phorbolester	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
;	NULL
10	NULL
ng	NULL
per	NULL
ml	NULL
)	NULL
and	NULL
the	NULL
plant	NULL
lectin	NULL
concanavalin	NULL
A	NULL
(	NULL
Con	NULL
A	NULL
;	NULL
2.5	NULL
ug	NULL
per	NULL
ml	NULL
)	NULL
;	NULL
the	NULL
other	NULL
half	NULL
was	NULL
used	NULL
as	NULL
the	NULL
uninduced	NULL
control	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
another	NULL
20	NULL
hr	NULL
,	NULL
sonicated	NULL
,	NULL
and	NULL
their	NULL
CAT	NULL
acitivity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

They	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
co-precipitation	NULL
procedure	NULL
(	NULL
20	NULL
)	NULL
and	NULL
shocked	NULL
with	NULL
25	NULL
%	NULL
dimethylsulfoxide	NULL
for	NULL
4	NULL
min	NULL
.	NULL

Ten	NULL
ug	NULL
DNA	NULL
were	NULL
normally	NULL
transfected	NULL
per	NULL
100	NULL
mm	NULL
plate	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
calculated	NULL
by	NULL
counting	NULL
the	NULL
radioactive	NULL
spots	NULL
of	NULL
thin	NULL
layer	NULL
chromatograms	NULL
and	NULL
normalized	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
protein	NULL
content	NULL
of	NULL
cell	NULL
lysates	NULL
.	NULL

The	NULL
'percentage	NULL
of	NULL
acetylation	NULL
(	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
corresponds	NULL
to	NULL
the	NULL
percentage	NULL
of	NULL
acetylated	NULL
chloramphenicol	NULL
determined	NULL
for	NULL
the	NULL
induced	NULL
cells	NULL
.	NULL

The	NULL
'ratio	NULL
of	NULL
induction	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
percentage	NULL
of	NULL
acetylation	NULL
of	NULL
stimulated	NULL
cells	NULL
by	NULL
the	NULL
percentage	NULL
of	NULL
acetylation	NULL
of	NULL
unstimulated	NULL
cells	NULL
.	NULL

DNA	NULL
cloning	NULL
The	NULL
recombinant	NULL
DNA	NULL
work	NULL
was	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
standard	NULL
recombinant	NULL
DNA	NULL
techniques	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Point	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
TCEd	NULL
sequence	NULL
using	NULL
the	NULL
Amersham	NULL
oligonuclotide-directed	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
system	NULL
.	NULL

The	NULL
mutated	NULL
enhancer	NULL
DNA	NULL
was	NULL
sequenced	NULL
and	NULL
introduced	NULL
into	NULL
the	NULL
CAT	NULL
vector	NULL
pBLCAT2	NULL
(	NULL
22	NULL
)	NULL
.	NULL

For	NULL
the	NULL
cloning	NULL
of	NULL
multiple	NULL
protein	NULL
binding	NULL
DNA	NULL
sequences	NULL
chemically	NULL
synthesized	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
on	NULL
20	NULL
%	NULL
polyacrylamide	NULL
(	NULL
PAA	NULL
)	NULL
-42	NULL
%	NULL
urea	NULL
gels	NULL
,	NULL
annealed	NULL
,	NULL
ligated	NULL
and	NULL
fractionated	NULL
on	NULL
2.5	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

Multiple	NULL
copies	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
introduced	NULL
in	NULL
front	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
in	NULL
pBLCAT	NULL
2	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
all	NULL
except	NULL
four	NULL
of	NULL
the	NULL
recombinant	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
work	NULL
has	NULL
been	NULL
described	NULL
(	NULL
4	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

They	NULL
were	NULL
:	NULL
SxTCEd-M	NULL
:	NULL
;	NULL
Five	NULL
copies	NULL
of	NULL
the	NULL
TCEd-M	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
with	NULL
Hind	NULL
III	NULL
ends	NULL
)	NULL
were	NULL
introduced	NULL
opposite	NULL
to	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
.	NULL

5xTCEd+kBcore	NULL
:	NULL
Five	NULL
copies	NULL
of	NULL
the	NULL
TCEd+kBcore	NULL
(	NULL
with	NULL
Hind	NULL
III	NULL
ends	NULL
,	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
were	NULL
introduced	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
.	NULL

SxkB+TCEdcore	NULL
:	NULL
Five	NULL
copies	NULL
of	NULL
the	NULL
kB+TCEd	NULL
core	NULL
(	NULL
with	NULL
Sal	NULL
I/Bam	NULL
HI	NULL
ends	NULL
as	NULL
the	NULL
kB	NULL
oligonucleotide	NULL
in	NULL
J16	NULL
:	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
were	NULL
introduced	NULL
between	NULL
the	NULL
Sal	NULL
I/Bam	NULL
HI	NULL
sites	NULL
of	NULL
pBLCAT2	NULL
.	NULL

Three	NULL
copies	NULL
were	NULL
oriented	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
,	NULL
two	NULL
(	NULL
the	NULL
2nd	NULL
and	NULL
4th	NULL
copy	NULL
)	NULL
in	NULL
the	NULL
opposite	NULL
direction	NULL
.	NULL

4xTCEd	NULL
(	NULL
4-C	NULL
)	NULL
:	NULL
Three	NULL
copies	NULL
of	NULL
TCEd	NULL
,	NULL
in	NULL
which	NULL
the	NULL
A	NULL
nucleotide	NULL
at	NULL
-199	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
,	NULL
the	NULL
fourth	NULL
distal	NULL
copy	NULL
in	NULL
the	NULL
opposite	NULL
direction	NULL
.	NULL

Preparation	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
Crude	NULL
nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
and	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Whole	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
TCEd	NULL
is	NULL
an	NULL
essential	NULL
sequence	NULL
motif	NULL
of	NULL
the	NULL
Interleukin	NULL
2	NULL
enhancer	NULL
and	NULL
a	NULL
factor	NULL
binding	NULL
site	NULL
.	NULL

A	NULL
.	NULL
)	NULL

The	NULL
effect	NULL
of	NULL
TCEd	NULL
mutations	NULL
on	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
IL-2	NULL
enhancer	NULL
in	NULL
El4	NULL
T	NULL
lymphoma	NULL
cells	NULL
.	NULL

The	NULL
construct	NULL
pNCAT2/1	NULL
+	NULL
contains	NULL
the	NULL
entire	NULL
N-2	NULL
enhancer	NULL
(	NULL
spanning	NULL
the	NULL
upstream	NULL
I1-2	NULL
DNA	NULL
sequences	NULL
from	NULL
position	NULL
-7	NULL
to	NULL
-293	NULL
;	NULL
see	NULL
ref	NULL
.	NULL

4	NULL
)	NULL
in	NULL
front	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
(	NULL
to	NULL
position	NULL
-109	NULL
)	NULL
of	NULL
CAT	NULL
vector	NULL
pBLCAT2	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
the	NULL
construct	NULL
pHICAT2/1+	NULL
(	NULL
-	NULL
199C	NULL
)	NULL
the	NULL
A	NULL
residue	NULL
at	NULL
position	NULL
-199	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
C	NULL
,	NULL
and	NULL
in	NULL
plICAT2/1	NULL
+	NULL
(	NULL
205/206	NULL
)	NULL
,	NULL
the	NULL
G	NULL
residues	NULL
at	NULL
positions	NULL
-205	NULL
and	NULL
-206	NULL
of	NULL
TCEd	NULL
'core	NULL
'	NULL
were	NULL
replaced	NULL
by	NULL
A	NULL
residues	NULL
,	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
the	NULL
A	NULL
residues	NULL
at	NULL
the	NULL
positions	NULL
-211	NULL
and	NULL
-214	NULL
of	NULL
TCEd	NULL
DNA	NULL
were	NULL
replaced	NULL
by	NULL
T	NULL
residues	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2A	NULL
for	NULL
the	NULL
TCEd	NULL
sequence	NULL
)	NULL
.	NULL

The	NULL
'	NULL
%	NULL
of	NULL
Acetylation	NULL
'	NULL
corresponds	NULL
to	NULL
the	NULL
acetylated	NULL
chloramphenicol	NULL
for	NULL
cell	NULL
lysates	NULL
from	NULL
uninduced	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
and	NULL
cells	NULL
induced	NULL
for	NULL
20hr	NULL
by	NULL
TPA/ConA	NULL
(	NULL
10ng/2.5ug	NULL
per	NULL
mi	NULL
)	NULL
.-	NULL
The	NULL
graph	NULL
shows	NULL
the	NULL
mean	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiment	NULL
.	NULL

B	NULL
.	NULL
)	NULL

The	NULL
TCEd	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
ubiquitous	NULL
factors	NULL
NF-kB	NULL
and	NULL
AP-3	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
protection	NULL
assay	NULL
.	NULL

An	NULL
I1-2	NULL
enhancer	NULL
probe	NULL
,	NULL
labelled	NULL
near	NULL
nucleotide	NULL
position	NULL
-293	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
2	NULL
al	NULL
of	NULL
an	NULL
AP-3	NULL
preparation	NULL
(	NULL
containing	NULL
about	NULL
2	NULL
ug/ml	NULL
protein	NULL
)	NULL
from	NULL
human	NULL
HeLa	NULL
cells	NULL
(	NULL
Ref	NULL
.	NULL

32	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
3	NULL
ul	NULL
or	NULL
1	NULL
al	NULL
TCF-1	NULL
from	NULL
murine	NULL
El4	NULL
lymphoma	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
3	NULL
gl	NULL
or	NULL
1	NULL
al	NULL
NF-kB	NULL
from	NULL
human	NULL
placenta	NULL
(	NULL
Ref	NULL
.	NULL

16	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
25	NULL
ug	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
.	NULL

The	NULL
boxes	NULL
indicate	NULL
the	NULL
binding	NULL
of	NULL
factors	NULL
NF-kB	NULL
and	NULL
AP-3	NULL
to	NULL
the	NULL
TCEd	NULL
and	NULL
further	NULL
I1-2	NULL
enhancer	NULL
motifs	NULL
,	NULL
e.g	NULL
.	NULL

to	NULL
the	NULL
upstream	NULL
promoter	NULL
sequence	NULL
(	NULL
UPS	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
T	NULL
cell	NULL
element	NULL
(	NULL
TCEp	NULL
)	NULL
and	NULL
the	NULL
upstream	NULL
site	NULL
1	NULL
(	NULL
US-1	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

cell	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
from	NULL
packed	NULL
deep-frozen	NULL
El4	NULL
lymphoma	NULL
cells	NULL
stimulated	NULL
for	NULL
4hr	NULL
by	NULL
TPA/Con	NULL
A	NULL
(	NULL
10	NULL
ng/2.5	NULL
ug	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
passed	NULL
over	NULL
a	NULL
heparin-agarose	NULL
column	NULL
,	NULL
and	NULL
protein	NULL
in	NULL
the	NULL
0.4	NULL
M	NULL
KCI	NULL
column	NULL
peak	NULL
was	NULL
used	NULL
in	NULL
DNase	NULL
I	NULL
protection	NULL
and	NULL
EMSA	NULL
experiments	NULL
.	NULL

For	NULL
the	NULL
enrichment	NULL
of	NULL
factors	NULL
,	NULL
proteins	NULL
in	NULL
the	NULL
0.4	NULL
M	NULL
KCI	NULL
fraction	NULL
were	NULL
dialysed	NULL
overnight	NULL
against	NULL
buffer	NULL
Z	NULL
(	NULL
25	NULL
mM	NULL
Hepes-KOH	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
12.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
M	NULL
KCI	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
)	NULL
and	NULL
subsequently	NULL
passed	NULL
over	NULL
a	NULL
$	NULL
300	NULL
Sephacryl	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
Z	NULL
.	NULL

The	NULL
resulting	NULL
fractions	NULL
were	NULL
tested	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Fractions	NULL
giving	NULL
similar	NULL
protection	NULL
patterns	NULL
over	NULL
the	NULL
TCEd	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
were	NULL
pooled	NULL
and	NULL
passed	NULL
over	NULL
a	NULL
DNA	NULL
affinity	NULL
column	NULL
containing	NULL
ligated	NULL
TCEd	NULL
(	NULL
or	NULL
kB	NULL
)	NULL
oligonucleotides	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Bound	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
0.6	NULL
M	NULL
KCI	NULL
(	NULL
in	NULL
buffer	NULL
Z	NULL
)	NULL
and	NULL
used	NULL
in	NULL
protein	NULL
binding	NULL
assays	NULL
.	NULL

DNA-protein	NULL
binding	NULL
assays	NULL
and	NULL
factor	NULL
analyses	NULL
In	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
chemically	NULL
synthesized	NULL
and	NULL
annealed	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
used	NULL
.	NULL

About	NULL
5000	NULL
cpm	NULL
(	NULL
equivalent	NULL
to	NULL
about	NULL
0.2	NULL
ng	NULL
)	NULL
of	NULL
P-end	NULL
labelled	NULL
probes	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
15	NULL
gl	NULL
with	NULL
4	NULL
ug	NULL
protein	NULL
(	NULL
of	NULL
crude	NULL
nuclear	NULL
extracts	NULL
or	NULL
from	NULL
the	NULL
0.4	NULL
M	NULL
KCl	NULL
peak	NULL
of	NULL
a	NULL
heparin-agarose	NULL
column	NULL
)	NULL
,	NULL
along	NULL
with	NULL
4	NULL
ug	NULL
poly	NULL
dI	NULL
-	NULL
dC	NULL
,	NULL
or	NULL
with	NULL
enriched	NULL
factors	NULL
as	NULL
described	NULL
(	NULL
4	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
fractionated	NULL
on	NULL
native	NULL
4	NULL
%	NULL
PAA	NULL
gels	NULL
at	NULL
200	NULL
V/15	NULL
cm	NULL
at	NULL
room	NULL
temperature	NULL
according	NULL
to	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

For	NULL
the	NULL
size	NULL
determination	NULL
of	NULL
TCF-1	NULL
polypeptides	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
an	NULL
aliquote	NULL
of	NULL
a	NULL
TCF-1	NULL
preparation	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
SDS-10	NULL
%	NULL
PAA	NULL
gel	NULL
,	NULL
followed	NULL
by	NULL
silver	NULL
staining	NULL
.	NULL

In	NULL
binding	NULL
studies	NULL
of	NULL
renatured	NULL
TCF-1	NULL
polypeptides	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
,	NULL
preparative	NULL
SDS-PAA	NULL
gels	NULL
were	NULL
cut	NULL
into	NULL
slices	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
extracted	NULL
,	NULL
renatured	NULL
(	NULL
27	NULL
)	NULL
and	NULL
used	NULL
in	NULL
EMSA	NULL
experiments	NULL
.	NULL

In	NULL
UV-crosslinking	NULL
experiments	NULL
,	NULL
protein	NULL
factors	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
bromodeoxyuridine-substituted	NULL
TCEd	NULL
probe	NULL
under	NULL
EMSA	NULL
conditions	NULL
,	NULL
fractionated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
EMSA	NULL
gel	NULL
and	NULL
UV	NULL
irradiated	NULL
for	NULL
15	NULL
min	NULL
(	NULL
28	NULL
)	NULL
.	NULL

A	NULL
fter	NULL
exposure	NULL
the	NULL
labelled	NULL
gel	NULL
slices	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
10	NULL
cm	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
fractionated	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
250	NULL
V.	NULL
In	NULL
proteolytic	NULL
clipping	NULL
band	NULL
shift	NULL
assays	NULL
(	NULL
26	NULL
)	NULL
the	NULL
labelled	NULL
DNA	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
factors	NULL
for	NULL
20	NULL
min	NULL
under	NULL
EMSA	NULL
conditions	NULL
,	NULL
0.2-1	NULL
unit	NULL
trypsin	NULL
or	NULL
Staphylococcus	NULL
aureus	NULL
protease	NULL
V8	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
20Â°C	NULL
.	NULL

The	NULL
resulting	NULL
tryptic	NULL
cleavage	NULL
products	NULL
were	NULL
fractionated	NULL
on	NULL
5	NULL
%	NULL
EMSA	NULL
gels	NULL
.	NULL

RESULTS	NULL
The	NULL
TCEd	NULL
is	NULL
a	NULL
functional	NULL
important	NULL
sequence	NULL
motif	NULL
of	NULL
the	NULL
II-2	NULL
enhancer	NULL
The	NULL
TCEd	NULL
sequence	NULL
GGGATTTCAC	NULL
corresponds	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
GPuGPuTTPyCAPy	NULL
which	NULL
was	NULL
detected	NULL
within	NULL
the	NULL
upstream	NULL
segments	NULL
of	NULL
numerous	NULL
lymphokine	NULL
genes	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
identified	NULL
the	NULL
TCEd	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
several	NULL
nuclear	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
ubiquitous	NULL
factors	NULL
NF-kB	NULL
and	NULL
AP-3	NULL
(	NULL
4	NULL
,	NULL
6-9	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
the	NULL
TCEd	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
an	NULL
inducible	NULL
,	NULL
T	NULL
cell-specific	NULL
proto-enhancer	NULL
element	NULL
when	NULL
it	NULL
was	NULL
cloned	NULL
in	NULL
multiple	NULL
copies	NULL
in	NULL
front	NULL
of	NULL
a	NULL
CAT	NULL
test	NULL
gene	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
TCEd	NULL
also	NULL
takes	NULL
part	NULL
in	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
entire	NULL
murine	NULL
II-2	NULL
enhancer	NULL
,	NULL
we	NULL
introduced	NULL
two	NULL
point	NULL
mutations	NULL
into	NULL
the	NULL
TCEd	NULL
'core	NULL
'	NULL
(	NULL
by	NULL
replacing	NULL
the	NULL
G	NULL
residues	NULL
at	NULL
the	NULL
positions	NULL
-205	NULL
and	NULL
-206	NULL
by	NULL
T	NULL
residues	NULL
)	NULL
and	NULL
two	NULL
A	NULL
to	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
5931	NULL
T	NULL
changes	NULL
at	NULL
the	NULL
positions	NULL
-211	NULL
and	NULL
-214	NULL
of	NULL
TCEd	NULL
DNA	NULL
.	NULL

When	NULL
such	NULL
mutated	NULL
II-2	NULL
enhancer	NULL
CAT	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
El4	NULL
cells	NULL
,	NULL
they	NULL
were	NULL
found	NULL
to	NULL
be	NULL
uninducible	NULL
by	NULL
TPA/ConA	NULL
,	NULL
and	NULL
their	NULL
constitutive	NULL
activity	NULL
increased	NULL
about	NULL
10fold	NULL
in	NULL
comparison	NULL
to	NULL
that	NULL
of	NULL
wild	NULL
type	NULL
enhancer	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
the	NULL
TCEd	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
establishement	NULL
of	NULL
overall	NULL
inducible	NULL
activity	NULL
of	NULL
murine	NULL
II-2	NULL
enhancer	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
.	NULL

One	NULL
base	NULL
pair	NULL
change	NULL
abolishes	NULL
the	NULL
T	NULL
cell-restricted	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
the	NULL
TCEd	NULL
motif	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
the	NULL
TCEd	NULL
motif	NULL
of	NULL
the	NULL
1-2	NULL
enhancer	NULL
differs	NULL
in	NULL
a	NULL
few	NULL
nucleotides	NULL
from	NULL
an	NULL
authentic	NULL
NF-kB	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
A	NULL
.	NULL
}	NULL

_OLIGOMUCLEOTIDES	NULL
:	NULL
Constructs	NULL
Sequences	NULL
215	NULL
191	NULL
s	NULL
x	NULL
Tord	NULL
agettGACCAAGA	NULL
5	NULL
x	NULL
TCEd-M	NULL
agctCGACCAAGA	NULL
5	NULL
x	NULL
TCEd	NULL
+	NULL
kBcore	NULL
4	NULL
x	NULL
TCEd	NULL
A-C	NULL
5	NULL
x	NULL
kB	NULL
+	NULL
TCEdcore	NULL
2	NULL
x	NULL
kB	NULL
(	NULL
=J16	NULL
)	NULL
*	NULL
2	NULL
x	NULL
kB-M	NULL
(	NULL
=J32	NULL
)	NULL
*	NULL
agcttGACCAAGA	NULL
togacAGA	NULL
Ratio	NULL
of	NULL
tio	NULL
.	NULL

of	NULL
Ratio	NULL
of	NULL
to	NULL
.	NULL

of	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
T-cell	NULL
specific	NULL
TCEd	NULL
is	NULL
converted	NULL
to	NULL
a	NULL
ubiquitously	NULL
acting	NULL
proto-enhancer	NULL
motif	NULL
by	NULL
one	NULL
base	NULL
pair	NULL
change	NULL
within	NULL
its	NULL
'core	NULL
'	NULL
sequence	NULL
.	NULL

4	NULL
.	NULL
)	NULL

TCEd	NULL
and	NULL
kB	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
transfection	NULL
experiments	NULL
.	NULL

Underlined	NULL
nucleotides	NULL
correspond	NULL
to	NULL
nucleotides	NULL
which	NULL
differ	NULL
from	NULL
the	NULL
TCEd	NULL
'core	NULL
'	NULL
sequence	NULL
.	NULL

For	NULL
the	NULL
best	NULL
alignment	NULL
of	NULL
sequences	NULL
two	NULL
spaces	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
TCEd	NULL
.	NULL

The	NULL
NF-kB	NULL
'core	NULL
'	NULL
sequence	NULL
(	NULL
which	NULL
is	NULL
contacted	NULL
by	NULL
NF-kB	NULL
:	NULL
see	NULL
Ref	NULL
.	NULL

31	NULL
)	NULL
is	NULL
boxed	NULL
.	NULL

The	NULL
kB-	NULL
(	NULL
and	NULL
kB-M-	NULL
)	NULL
sequences	NULL
(	NULL
labelled	NULL
by	NULL
a	NULL
*	NULL
)	NULL
are	NULL
from	NULL
the	NULL
Ig-kappa	NULL
enhancer	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
recognition	NULL
sites	NULL
for	NULL
restriction	NULL
enzymes	NULL
are	NULL
written	NULL
in	NULL
lower	NULL
case	NULL
.	NULL

B	NULL
.	NULL
)	NULL

Determination	NULL
of	NULL
activity	NULL
of	NULL
TCEd-	NULL
and	NULL
kB-vectors	NULL
in	NULL
El4	NULL
lymphoma	NULL
cells	NULL
and	NULL
in	NULL
tk	NULL
HeLa	NULL
cells	NULL
.	NULL

CAT	NULL
experiments	NULL
.	NULL

For	NULL
the	NULL
construction	NULL
of	NULL
CAT	NULL
vectors	NULL
,	NULL
complementary	NULL
single-stranded	NULL
oligonucleotides	NULL
were	NULL
chemically	NULL
synthesized	NULL
(	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
sticky	NULL
ends	NULL
for	NULL
restriction	NULL
endonucleases	NULL
)	NULL
,	NULL
annealed	NULL
,	NULL
phosphorylated	NULL
,	NULL
polymerized	NULL
and	NULL
introduced	NULL
as	NULL
multimers	NULL
in	NULL
front	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
of	NULL
CAT	NULL
plasmid	NULL
pBLCAT2	NULL
(	NULL
22	NULL
)	NULL
.	NULL

J16	NULL
and	NULL
J32	NULL
(	NULL
*	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
Pierce	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
'Ratio	NULL
of	NULL
Induction	NULL
'	NULL
corresponds	NULL
to	NULL
the	NULL
percentage	NULL
of	NULL
'*C-chloramphenicol	NULL
acetylation	NULL
by	NULL
the	NULL
extracts	NULL
of	NULL
induced	NULL
cells	NULL
divided	NULL
by	NULL
those	NULL
of	NULL
uninduced	NULL
cells	NULL
.	NULL

The	NULL
*	NULL
%	NULL
of	NULL
Acetylation	NULL
'	NULL
corresponds	NULL
to	NULL
the	NULL
acetylated	NULL
chloramphenicol	NULL
for	NULL
cell	NULL
lysates	NULL
of	NULL
induced	NULL
cells	NULL
.	NULL

The	NULL
autoradiographs	NULL
below	NULL
show	NULL
the	NULL
result	NULL
of	NULL
a	NULL
representative	NULL
transfection	NULL
experiment	NULL
with	NULL
TCEd	NULL
(	NULL
lanes	NULL
1+2	NULL
)	NULL
,	NULL
TCEd+kB	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
(	NULL
3+4	NULL
)	NULL
or	NULL
pBLCAT2	NULL
DNA	NULL
(	NULL
5+6	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
induced	NULL
(	NULL
+	NULL
)	NULL
and	NULL
uninduced	NULL
E14	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
CAT	NULL
assays	NULL
.	NULL

5932	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
order	NULL
to	NULL
assess	NULL
whether	NULL
these	NULL
subtle	NULL
sequence	NULL
differences	NULL
play	NULL
any	NULL
role	NULL
in	NULL
the	NULL
establishment	NULL
of	NULL
T	NULL
cell-restricted	NULL
,	NULL
inducible	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
TCEd	NULL
,	NULL
we	NULL
synthesized	NULL
TCEd	NULL
oligonucleotides	NULL
with	NULL
a	NULL
NF-kB	NULL
'core	NULL
'	NULL
and	NULL
,	NULL
vice	NULL
versa	NULL
,	NULL
NF-kB	NULL
oligonucleotides	NULL
with	NULL
a	NULL
TCEd	NULL
'core	NULL
'	NULL
(	NULL
the	NULL
NF-kB	NULL
'core	NULL
'	NULL
is	NULL
defined	NULL
as	NULL
the	NULL
stretch	NULL
of	NULL
nucleotides	NULL
of	NULL
NF-kB	NULL
binding	NULL
site	NULL
contacting	NULL
NF-kB	NULL
:	NULL
see	NULL
31	NULL
)	NULL
.	NULL

As	NULL
for	NULL
the	NULL
TCEd	NULL
,	NULL
the	NULL
double-stranded	NULL
oligonucleotides	NULL
,	NULL
designated	NULL
as	NULL
TCEd	NULL
+kBcore	NULL
and	NULL
kB+TCEdcore	NULL
,	NULL
were	NULL
cloned	NULL
in	NULL
five	NULL
copies	NULL
in	NULL
front	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
into	NULL
the	NULL
CAT	NULL
vector	NULL
pBLCAT2	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
their	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
El4	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
the	NULL
constructs	NULL
5	NULL
XTCEd	NULL
and	NULL
2xkB	NULL
(	NULL
also	NULL
designated	NULL
as	NULL
J16	NULL
:	NULL
see	NULL
31	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
same	NULL
cells	NULL
in	NULL
parallel	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
show	NULL
that	NULL
the	NULL
conversion	NULL
of	NULL
TCEd	NULL
to	NULL
a	NULL
TCEd+kBcore	NULL
sequence	NULL
had	NULL
a	NULL
dramatic	NULL
effect	NULL
on	NULL
the	NULL
inducible	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
TCEd	NULL
derivative	NULL
:	NULL
In	NULL
El4	NULL
cells	NULL
,	NULL
the	NULL
inducible	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
5	NULL
XTCEd+kBcore	NULL
construct	NULL
appeared	NULL
to	NULL
be	NULL
manyfold	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
the	NULL
5xTCEd	NULL
construct	NULL
,	NULL
and	NULL
in	NULL
HeLa	NULL
cells	NULL
upon	NULL
induction	NULL
the	NULL
SxTCEd	NULL
+kBcore	NULL
DNA	NULL
was	NULL
as	NULL
active	NULL
as	NULL
constructs	NULL
containing	NULL
genuine	NULL
NF-kB	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
and	NULL
similar	NULL
to	NULL
the	NULL
mutated	NULL
TCEd-M	NULL
construct	NULL
,	NULL
the	NULL
5	NULL
x	NULL
kB	NULL
+TCEdcore	NULL
construct	NULL
was	NULL
found	NULL
to	NULL
be	NULL
inactive	NULL
in	NULL
both	NULL
El4	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

NF-kB	NULL
contacts	NULL
all	NULL
G	NULL
residues	NULL
within	NULL
its	NULL
semi-palindromic	NULL
DNA	NULL
binding	NULL
motif	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
AT	NULL
base	NULL
pair	NULL
between	NULL
the	NULL
two	NULL
CG	NULL
base	NULL
pairs	NULL
located	NULL
in	NULL
the	NULL
proximal	NULL
half	NULL
of	NULL
the	NULL
TCEd	NULL
impairs	NULL
the	NULL
semi-palindromic	NULL
structure	NULL
of	NULL
a	NULL
NF-kB	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
prompted	NULL
us	NULL
to	NULL
assume	NULL
that	NULL
the	NULL
AT	NULL
base	NULL
pair	NULL
at	NULL
position	NULL
-199	NULL
of	NULL
TCEd	NULL
DNA	NULL
impairs	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
(	NULL
or	NULL
of	NULL
a	NULL
kB-like	NULL
factor	NULL
)	NULL
to	NULL
the	NULL
TCEd	NULL
,	NULL
and	NULL
,	NULL
as	NULL
functional	NULL
consequence	NULL
,	NULL
could	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
inactivity	NULL
of	NULL
5	NULL
X	NULL
TCEd	NULL
construct	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
test	NULL
the	NULL
latter	NULL
hypothesis	NULL
,	NULL
we	NULL
synthesized	NULL
TCEd	NULL
A-C	NULL
oligonucleotides	NULL
containing	NULL
a	NULL
CG	NULL
base	NULL
pair	NULL
instead	NULL
the	NULL
AT	NULL
pair	NULL
at	NULL
position	NULL
-199	NULL
and	NULL
tested	NULL
their	NULL
activity	NULL
in	NULL
El4	NULL
cells	NULL
and	NULL
HeLa	NULL
6	NULL
opbnltrathanld	NULL
cs	NULL
4.0	NULL
,	NULL
9	NULL
.	NULL

1011	NULL
dine	NULL
as	NULL
tnt	NULL
4	NULL
4	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
inducible	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
TCEd	NULL
motifs	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
an	NULL
inducible	NULL
,	NULL
NF-kB	NULL
like	NULL
factor	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

A	NULL
.	NULL
)	NULL

4	NULL
ug	NULL
protein	NULL
of	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
HeLa	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
or	NULL
from	NULL
HeLa	NULL
cells	NULL
induced	NULL
with	NULL
50	NULL
ng/ml	NULL
TPA	NULL
for	NULL
4hr	NULL
(	NULL
+	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
*P-labelled	NULL
DNA	NULL
probes	NULL
as	NULL
indicated	NULL
.	NULL

Note	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
inducible	NULL
,	NULL
NF-kB	NULL
like	NULL
factor	NULL
{	NULL
indicated	NULL
by	NULL
k	NULL
)	NULL
after	NULL
the	NULL
incubation	NULL
of	NULL
an	NULL
authentic	NULL
NF-kB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
Ig-kappa	NULL
enhancer	NULL
(	NULL
kB	NULL
)	NULL
,	NULL
the	NULL
TCEd+kBcore	NULL
and	NULL
TCEd	NULL
A-C	NULL
probes	NULL
.	NULL

B	NULL
.	NULL
)	NULL

Competition	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
NF-kB	NULL
like	NULL
factor	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
TPA-induced	NULL
HeLa	NULL
cells	NULL
.	NULL

A	NULL
20fold	NULL
(	NULL
lanes	NULL
1,3,5,7,9,11	NULL
)	NULL
or	NULL
a	NULL
200fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
Ig-k	NULL
probe	NULL
(	NULL
lanes	NULL
2,4,6,8,10,12	NULL
)	NULL
was	NULL
added	NULL
for	NULL
competition	NULL
.	NULL

cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
this	NULL
base	NULL
pair	NULL
substitution	NULL
had	NULL
about	NULL
the	NULL
same	NULL
effect	NULL
as	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
kB	NULL
'core	NULL
'	NULL
into	NULL
the	NULL
TCEd	NULL
motif	NULL
:	NULL
the	NULL
5	NULL
XTCEd	NULL
A-C	NULL
construct	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
very	NULL
active	NULL
in	NULL
El4	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
A-C	NULL
transition	NULL
also	NULL
has	NULL
an	NULL
influence	NULL
on	NULL
the	NULL
overall	NULL
1-2	NULL
enhancer	NULL
activity	NULL
in	NULL
El4	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
we	NULL
introduced	NULL
this	NULL
mutation	NULL
into	NULL
the	NULL
entire	NULL
enhancer	NULL
and	NULL
tested	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
resulting	NULL
pNCAT2/1+	NULL
(	NULL
-199C	NULL
)	NULL
construct	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
A-C	NULL
replacement	NULL
resulted	NULL
in	NULL
a	NULL
severalfold	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
1-2	NULL
enhancer	NULL
in	NULL
E14	NULL
T	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
the	NULL
note	NULL
in	NULL
its	NULL
legend	NULL
)	NULL
,	NULL
and	NULL
to	NULL
an	NULL
about	NULL
2.Sfold	NULL
induction	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
B.H	NULL
.	NULL

et	NULL
al	NULL
,	NULL
in	NULL
prep	NULL
.	NULL
)	NULL

.	NULL

This	NULL
again	NULL
demonstrates	NULL
that	NULL
the	NULL
TCEd	NULL
is	NULL
an	NULL
important	NULL
sequence	NULL
motif	NULL
necessary	NULL
for	NULL
the	NULL
establishement	NULL
of	NULL
enhancer	NULL
activity	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
also	NULL
shows	NULL
that	NULL
in	NULL
HeLa	NULL
cells	NULL
the	NULL
activity	NULL
of	NULL
more	NULL
sequence	NULL
elements	NULL
than	NULL
the	NULL
'converted	NULL
'	NULL
TCEd	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
efficient	NULL
functioning	NULL
of	NULL
the	NULL
I1-2	NULL
enhancer	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

The	NULL
inducible	NULL
activity	NULL
of	NULL
TCEd	NULL
constructs	NULL
correlates	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
protein	NULL
factors	NULL
The	NULL
results	NULL
of	NULL
transient	NULL
transfection	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
one	NULL
or	NULL
a	NULL
few	NULL
TCEd	NULL
nucleotides	NULL
is	NULL
accompanied	NULL
with	NULL
distinct	NULL
changes	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
transacting	NULL
factors	NULL
.	NULL

In	NULL
order	NULL
to	NULL
elucidate	NULL
which	NULL
DNA	NULL
binding	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
mutated	NULL
TCEd	NULL
derivatives	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
crude	NULL
nuclear	NULL
protein	NULL
extracts	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
with	NULL
TCEd	NULL
and	NULL
kB	NULL
probes	NULL
in	NULL
EMSA	NULL
experiments	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
of	NULL
TPA-treated	NULL
HeLa	NULL
cells	NULL
one	NULL
inducible	NULL
factor	NULL
was	NULL
found	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
genuine	NULL
NF-kB	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
binding	NULL
could	NULL
be	NULL
specifically	NULL
competed	NULL
by	NULL
a	NULL
50-200fold	NULL
molar	NULL
excess	NULL
of	NULL
kB	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
factor	NULL
complex	NULL
should	NULL
be	NULL
due	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
authentic	NULL
NF-kB	NULL
.	NULL

A	NULL
very	NULL
similar	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
the	NULL
TCEd	NULL
+kBcore	NULL
and	NULL
TCEd	NULL
A-C	NULL
probes	NULL
,	NULL
whereas	NULL
,	NULL
in	NULL
most	NULL
of	NULL
our	NULL
experiments	NULL
,	NULL
the	NULL
incubation	NULL
of	NULL
TCEd	NULL
,	NULL
TCEd-M	NULL
and	NULL
kB+TCEdcore	NULL
probes	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
occurrence	NULL
of	NULL
an	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Factors	NULL
other	NULL
than	NULL
the	NULL
ubigitious	NULL
NF-kB	NULL
bind	NULL
to	NULL
the	NULL
TCEd	NULL
motifs	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
induced	NULL
E14	NULL
lymphoma	NULL
cells	NULL
.	NULL

A	NULL
.	NULL
)	NULL

4	NULL
ug	NULL
protein	NULL
of	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
El4	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
or	NULL
from	NULL
El4	NULL
cells	NULL
induced	NULL
for	NULL
4hr	NULL
with	NULL
10ng/ml	NULL
TPA	NULL
and	NULL
2.5	NULL
ug/ml	NULL
ConA	NULL
(	NULL
+	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
labelled	NULL
probes	NULL
as	NULL
indicated	NULL
.	NULL

Note	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
NF-kB	NULL
like	NULL
complex	NULL
(	NULL
k	NULL
)	NULL
and	NULL
of	NULL
factor	NULL
complexes	NULL
specific	NULL
for	NULL
the	NULL
TCEd	NULL
probes	NULL
.	NULL

The	NULL
most	NULL
prominent	NULL
TCEd	NULL
complex	NULL
is	NULL
indicated	NULL
(	NULL
T	NULL
)	NULL
.	NULL

B	NULL
.	NULL
)	NULL

Competition	NULL
of	NULL
NF-kB	NULL
and	NULL
TCEd	NULL
factor	NULL
binding	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
induced	NULL
El4	NULL
cells	NULL
by	NULL
kB	NULL
DNA	NULL
.	NULL

A	NULL
20	NULL
to	NULL
200fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
Ig-k	NULL
DNA	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
incubations	NULL
containing	NULL
*Â°P-labelled	NULL
kB	NULL
,	NULL
TCEd	NULL
and	NULL
TCEd	NULL
A-C	NULL
probes	NULL
.	NULL

Note	NULL
the	NULL
competition	NULL
of	NULL
NF-kB	NULL
complex	NULL
and	NULL
the	NULL
resistance	NULL
of	NULL
TCEd	NULL
factor	NULL
complex	NULL
formation	NULL
.	NULL

inducible	NULL
factor	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
in	NULL
HeLa	NULL
cells	NULL
extracts	NULL
to	NULL
the	NULL
DNA	NULL
correlates	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
proto-enhancer	NULL
motifs	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

More	NULL
complex	NULL
results	NULL
with	NULL
respect	NULL
to	NULL
factor	NULL
binding	NULL
and	NULL
activity	NULL
were	NULL
obtained	NULL
for	NULL
El4	NULL
cells	NULL
.	NULL

Again	NULL
,	NULL
no	NULL
inducible	NULL
factor	NULL
complex	NULL
was	NULL
formed	NULL
after	NULL
incubation	NULL
with	NULL
the	NULL
functional	NULL
inactive	NULL
TCEd-M	NULL
and	NULL
kB+TCEdcore	NULL
oligonucleotides	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
of	NULL
a	NULL
kB-probe	NULL
resulted	NULL
in	NULL
one	NULL
inducible	NULL
,	NULL
NF-kB	NULL
like	NULL
factor	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
more	NULL
than	NULL
one	NULL
inducible	NULL
factor	NULL
complex	NULL
was	NULL
formed	NULL
after	NULL
incubation	NULL
with	NULL
the	NULL
TCEd	NULL
derivatives	NULL
TCEd+kBcore	NULL
and	NULL
TCEd	NULL
C-A	NULL
and	NULL
,	NULL
yet	NULL
more	NULL
important	NULL
,	NULL
with	NULL
the	NULL
TCEd	NULL
motif	NULL
itself	NULL
.	NULL

The	NULL
most	NULL
prominent	NULL
complex	NULL
,	NULL
designated	NULL
as	NULL
T	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
was	NULL
observed	NULL
with	NULL
all	NULL
three	NULL
TCEd	NULL
probes	NULL
.	NULL

This	NULL
complex	NULL
exhibits	NULL
a	NULL
somewhat	NULL
faster	NULL
electrophoretic	NULL
mobility	NULL
than	NULL
the	NULL
NF-kB	NULL
complex	NULL
,	NULL
and	NULL
a	NULL
20	NULL
to	NULL
200fold	NULL
molar	NULL
excess	NULL
of	NULL
kB-DNA	NULL
(	NULL
which	NULL
efficiently	NULL
competes	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
to	NULL
its	NULL
cognate	NULL
sequence	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
its	NULL
binding	NULL
to	NULL
TCEd	NULL
DNA	NULL
1.0	NULL
$	NULL
300	NULL
A	NULL
B	NULL
0.8	NULL
A	NULL
D	NULL
,	NULL
0.6	NULL
'./	NULL
Â¥a	NULL
o	NULL
I	NULL
Â£	NULL
|	NULL
i	NULL
B	NULL
p	NULL
-TCF-1	NULL
oa	NULL
|	NULL
l	NULL
Â¥	NULL
--	NULL
]	NULL
-TCF-2	NULL
|	NULL
4	NULL
``	NULL
wf	NULL
)	NULL
-tcr-3	NULL
k	NULL
Â®	NULL
|	NULL
h	NULL
0.2	NULL
/	NULL
â	NULL
f	NULL
â	NULL
ï¬	NULL
'	NULL
4	NULL
AA	NULL
60	NULL
70	NULL
80	NULL
90	NULL
FRACTIONS	NULL
30	NULL
40	NULL
50	NULL
C	NULL
PS	NULL
TREp	NULL
TCEp	NULL
TCEq	NULL
US1	NULL
US2	NULL
S3	NULL
-	NULL
Â«	NULL
Â»	NULL
Â»	NULL
#	NULL
>	NULL
+	NULL
Â«	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Isolation	NULL
of	NULL
TCEd	NULL
factors	NULL
TCFE-1	NULL
,	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
from	NULL
induced	NULL
El4	NULL
lymphoma	NULL
cells	NULL
.	NULL

Whole	NULL
cell	NULL
protein	NULL
extract	NULL
from	NULL
induced	NULL
El4	NULL
cells	NULL
was	NULL
passed	NULL
over	NULL
a	NULL
heparin/agarose	NULL
column	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
in	NULL
the	NULL
0.4	NULL
M	NULL
KCI	NULL
fraction	NULL
was	NULL
subsequently	NULL
fractionated	NULL
on	NULL
a	NULL
$	NULL
300	NULL
Sephacryl	NULL
column	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
fractions	NULL
giving	NULL
similar	NULL
DNase	NULL
I	NULL
protection	NULL
patterns	NULL
over	NULL
the	NULL
TCEd	NULL
(	NULL
B	NULL
)	NULL
were	NULL
pooled	NULL
to	NULL
the	NULL
fractions	NULL
A	NULL
and	NULL
B	NULL
,	NULL
and	NULL
each	NULL
pool	NULL
was	NULL
passed	NULL
four	NULL
times	NULL
over	NULL
a	NULL
TCEd	NULL
DNA	NULL
affinity	NULL
column	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
bound	NULL
protein	NULL
of	NULL
each	NULL
fraction	NULL
was	NULL
used	NULL
in	NULL
EMSA	NULL
experiments	NULL
using	NULL
TCEd	NULL
DNA	NULL
as	NULL
probe	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
factor	NULL
complexes	NULL
TCF-1	NULL
,	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
are	NULL
indicated	NULL
.	NULL

Lane	NULL
G	NULL
in	NULL
B	NULL
shows	NULL
a	NULL
G	NULL
specific	NULL
sequencing	NULL
reaction	NULL
.	NULL

BSA	NULL
:	NULL
Two	NULL
control	NULL
incubations	NULL
in	NULL
which	NULL
254g	NULL
bovine	NULL
serum	NULL
albumin	NULL
was	NULL
added	NULL
instead	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

For	NULL
the	NULL
designation	NULL
of	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
B	NULL
see	NULL
ref	NULL
.	NULL

4	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
5933	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
factors	NULL
other	NULL
than	NULL
NF-kB	NULL
bind	NULL
to	NULL
the	NULL
TCEd	NULL
in	NULL
El4	NULL
cells	NULL
.	NULL

Three	NULL
individual	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
TCEd	NULL
in	NULL
extracts	NULL
of	NULL
induced	NULL
El4	NULL
lymphoma	NULL
cells	NULL
The	NULL
heterogeneity	NULL
of	NULL
TCEd	NULL
binding	NULL
factors	NULL
in	NULL
the	NULL
crude	NULL
nuclear	NULL
extracts	NULL
of	NULL
El4	NULL
cells	NULL
prompted	NULL
us	NULL
to	NULL
enrich	NULL
the	NULL
TCEd	NULL
factors	NULL
from	NULL
these	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
a	NULL
whole	NULL
cell	NULL
protein	NULL
extract	NULL
of	NULL
cells	NULL
induced	NULL
by	NULL
10	NULL
ng/ml	NULL
TPA	NULL
and	NULL
2.5	NULL
ug/ml	NULL
ConA	NULL
for	NULL
4hr	NULL
was	NULL
loaded	NULL
onto	NULL
a	NULL
heparin-agarose	NULL
column	NULL
,	NULL
and	NULL
the	NULL
majority	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
column	NULL
were	NULL
eluted	NULL
by	NULL
0.4	NULL
M	NULL
KCI	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
protein	NULL
of	NULL
0.4M	NULL
KCl	NULL
peak	NULL
was	NULL
size-fractionated	NULL
on	NULL
a	NULL
preparative	NULL
$	NULL
300	NULL
Sephacryl	NULL
column	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
of	NULL
$	NULL
300	NULL
column	NULL
fractions	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
binding	NULL
to	NULL
TCEd	NULL
DNA	NULL
in	NULL
DNase	NULL
I	NULL
footprint	NULL
protection	NULL
experiments	NULL
using	NULL
an	NULL
II-2	NULL
enhancer	NULL
DNA	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
the	NULL
incubation	NULL
of	NULL
the	NULL
$	NULL
300	NULL
fractions	NULL
with	NULL
the	NULL
I-2	NULL
enhancer	NULL
DNA	NULL
resulted	NULL
in	NULL
two	NULL
divergent	NULL
DNaselI	NULL
footprint	NULL
protection	NULL
patterns	NULL
over	NULL
the	NULL
TCEd	NULL
:	NULL
a	NULL
very	NULL
strong	NULL
,	NULL
clear-cut	NULL
pattern	NULL
when	NULL
the	NULL
fractions	NULL
no	NULL
.	NULL

55-65	NULL
were	NULL
used	NULL
,	NULL
A	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
TCF-wn	NULL
Â«	NULL
bin	NULL
=-	NULL
1=	NULL
.	NULL

cap	NULL
ï¬	NULL
'	NULL
ï¬-	NULL
we	NULL
wth	NULL
wig	NULL
Â»	NULL
wen	NULL
e	NULL
wam	NULL
u	NULL
Â»	NULL
.	NULL

@	NULL
Â»	NULL
3	NULL
Â«	NULL
an	NULL
6D	NULL
Â«	NULL
a	NULL
_	NULL
Cp	NULL
k	NULL
TCEy	NULL
Â»	NULL
A	NULL
probe	NULL
.	NULL

|	NULL
<	NULL
TCEq	NULL
>	NULL
<	NULL
kB	NULL
>	NULL
i	NULL
tory	NULL
E	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
TCEd	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
factors	NULL
TCF-1	NULL
,	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
of	NULL
El4	NULL
lymphoma	NULL
cells	NULL
.	NULL

EMSA	NULL
experiments	NULL
.	NULL

A	NULL
.	NULL
)	NULL

TCF-/	NULL
has	NULL
a	NULL
stronger	NULL
binding	NULL
affinity	NULL
to	NULL
TCEd	NULL
than	NULL
kB	NULL
DNA	NULL
.	NULL

TCF-1	NULL
(	NULL
fraction	NULL
A	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
TCEd	NULL
probe	NULL
without	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
a	NULL
25	NULL
fold	NULL
molar	NULL
excess	NULL
of	NULL
TCEd	NULL
DNA	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
kB	NULL
DNA	NULL
(	NULL
from	NULL
the	NULL
Ig-k	NULL
enhancer	NULL
:	NULL
Ref	NULL
.	NULL

30	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
with	NULL
a	NULL
250	NULL
fold	NULL
excess	NULL
of	NULL
TCEd	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
kB	NULL
DNA	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

B	NULL
.	NULL
)	NULL

The	NULL
TCFs	NULL
correspond	NULL
to	NULL
individual	NULL
DNA	NULL
binding	NULL
factors	NULL
.	NULL

Fraction	NULL
B	NULL
(	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
TCEd	NULL
probe	NULL
(	NULL
lanes	NULL
1-7	NULL
and	NULL
14-17	NULL
)	NULL
or	NULL
a	NULL
kB	NULL
probe	NULL
of	NULL
Ig-k	NULL
enhancer	NULL
(	NULL
lanes	NULL
8-13	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
1	NULL
,	NULL
4	NULL
ug	NULL
protein	NULL
was	NULL
used	NULL
from	NULL
the	NULL
0.4	NULL
M	NULL
KCI	NULL
fraction	NULL
of	NULL
a	NULL
heparin/agarose	NULL
column	NULL
on	NULL
which	NULL
protein	NULL
from	NULL
induced	NULL
El4	NULL
cells	NULL
was	NULL
fractionated	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
2	NULL
,	NULL
8	NULL
and	NULL
14	NULL
no	NULL
specific	NULL
competitor	NULL
DNA	NULL
was	NULL
added	NULL
.	NULL

In	NULL
the	NULL
competition	NULL
assays	NULL
,	NULL
a	NULL
250	NULL
fold	NULL
excess	NULL
of	NULL
the	NULL
following	NULL
oligonucleotides	NULL
was	NULL
used	NULL
with	NULL
the	NULL
indicated	NULL
results	NULL
:	NULL
Binding	NULL
Lanes	NULL
Designation	NULL
Sequences	NULL
of	NULL
TCFS	NULL
:	NULL
-215	NULL
-191	NULL
10	NULL
2	NULL
3	NULL
3+9	NULL
TeBd	NULL
agcttGACCAAGAq	NULL
CTAAATCa	NULL
+	NULL
+	NULL
4+10	NULL
_	NULL
TcBda-M	NULL
-+	NULL
5+11	NULL
TCEd+kBcore	NULL
agcttGACCMGAj-GGGAE	NULL
â	NULL
ITTC	NULL
CTAAATCa	NULL
Â¥	NULL
~	NULL
6+12	NULL
-	NULL
kB+TCBEdcore	NULL
tcgacAGA4GGGA-TTTCACGAGAGGg	NULL
-	NULL
0	NULL
+	NULL
+	NULL
7+13	NULL
|	NULL
us-1	NULL
-	NULL
+	NULL
15	NULL
SV40-	NULL
'core	NULL
'	NULL
gatctGGGACTTTCGACa	NULL
+o	NULL
+	NULL
+	NULL
16	NULL
p5S5-112-Ra	NULL
tegacGecac	NULL
+0	NULL
-	NULL
17	NULL
TCEp	NULL
agctTCAGTGTAT	NULL
%	NULL
Alï¬a	NULL
-o	NULL
+	NULL
+	NULL
#	NULL
The	NULL
US-1	NULL
(	NULL
upstream	NULL
site-1	NULL
)	NULL
and	NULL
TCEp	NULL
(	NULL
proximal	NULL
T	NULL
cell	NULL
element	NULL
)	NULL
correspond	NULL
to	NULL
AP-3	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
I1-2	NULL
enhancer	NULL
which	NULL
span	NULL
the	NULL
enhancer	NULL
sequences	NULL
from	NULL
position	NULL
-211	NULL
to	NULL
-236	NULL
and	NULL
-158	NULL
to	NULL
-183	NULL
,	NULL
respectively	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
SV40-'core	NULL
'	NULL
corresponds	NULL
to	NULL
the	NULL
AP-3/NF-kB	NULL
binding	NULL
site	NULL
of	NULL
SV40	NULL
enhancer	NULL
used	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
AP-3	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
NF-kB	NULL
like	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
p55-Il-2	NULL
receptor	NULL
a	NULL
gene	NULL
(	NULL
33	NULL
)	NULL
is	NULL
part	NULL
of	NULL
an	NULL
oligonucleotide	NULL
which	NULL
contains	NULL
the	NULL
DNA	NULL
between	NULL
the	NULL
positions	NULL
from	NULL
-251	NULL
to	NULL
-274	NULL
of	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
II-2-Ra	NULL
gene	NULL
.	NULL

The	NULL
NF-kB	NULL
core	NULL
sequence	NULL
(	NULL
31	NULL
)	NULL
is	NULL
boxed	NULL
.	NULL

Nucleotides	NULL
within	NULL
the	NULL
boxed	NULL
sequences	NULL
that	NULL
differ	NULL
from	NULL
the	NULL
TCEd	NULL
'core	NULL
'	NULL
are	NULL
underlined	NULL
.	NULL

Nucleotides	NULL
of	NULL
restriction	NULL
enzyme	NULL
recognition	NULL
sites	NULL
are	NULL
written	NULL
in	NULL
lower	NULL
case	NULL
.	NULL

5934	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
and	NULL
a	NULL
broad	NULL
,	NULL
less	NULL
complete	NULL
protection	NULL
with	NULL
the	NULL
fractions	NULL
65-80	NULL
.	NULL

Passage	NULL
of	NULL
pooled	NULL
fractions	NULL
55-65	NULL
(	NULL
pool	NULL
A	NULL
)	NULL
over	NULL
a	NULL
TCEd	NULL
DNA	NULL
affinity	NULL
column	NULL
resulted	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
one	NULL
factor	NULL
to	NULL
the	NULL
column	NULL
.	NULL

This	NULL
factor	NULL
,	NULL
which	NULL
we	NULL
designated	NULL
as	NULL
TCF-1	NULL
,	NULL
corresponds	NULL
in	NULL
its	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
and	NULL
DNA	NULL
binding	NULL
properties	NULL
to	NULL
factor	NULL
T	NULL
in	NULL
crude	NULL
nuclear	NULL
extracts	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
TCF-1	NULL
two	NULL
further	NULL
factors	NULL
were	NULL
detected	NULL
in	NULL
pool	NULL
B	NULL
which	NULL
we	NULL
designated	NULL
as	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
.	NULL

In	NULL
order	NULL
to	NULL
characterize	NULL
the	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
TCFs	NULL
,	NULL
we	NULL
investigated	NULL
their	NULL
binding	NULL
to	NULL
several	NULL
TCEd/kB	NULL
like	NULL
sites	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
TCF-1	NULL
strongly	NULL
binds	NULL
to	NULL
TCEd	NULL
DNA	NULL
,	NULL
but	NULL
only	NULL
weakly	NULL
to	NULL
kB	NULL
DNA	NULL
.	NULL

While	NULL
the	NULL
binding	NULL
of	NULL
TCF-1	NULL
to	NULL
TCEd	NULL
DNA	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
a	NULL
25fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
TCEd	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
more	NULL
than	NULL
a	NULL
250fold	NULL
excess	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

A	NULL
better	NULL
competition	NULL
of	NULL
TCF-1	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
same	NULL
excess	NULL
of	NULL
TCEd	NULL
+kBcore	NULL
DNA	NULL
(	NULL
lane	NULL
5	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
kB	NULL
DNAs	NULL
of	NULL
SV40	NULL
enhancer	NULL
and	NULL
1-2	NULL
a	NULL
receptor	NULL
genes	NULL
(	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

TCF-2	NULL
and	NULL
TCF-3	NULL
appear	NULL
to	NULL
represent	NULL
specific	NULL
TCEd	NULL
'core	NULL
'	NULL
binding	NULL
factors	NULL
because	NULL
both	NULL
factors	NULL
did	NULL
neither	NULL
bind	NULL
to	NULL
the	NULL
TCEd	NULL
when	NULL
its	NULL
'core	NULL
'	NULL
was	NULL
converted	NULL
to	NULL
a	NULL
kB	NULL
'core	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
nor	NULL
to	NULL
a	NULL
canonical	NULL
kB	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
8-13	NULL
)	NULL
.	NULL

TCF-2	NULL
,	NULL
but	NULL
not	NULL
TCF-3	NULL
,	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
TCEd-M	NULL
and	NULL
US-1	NULL
oligonucleotides	NULL
both	NULL
of	NULL
which	NULL
differ	NULL
substantially	NULL
in	NULL
their	NULL
'core	NULL
'	NULL
from	NULL
the	NULL
TCEd	NULL
'core	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Since	NULL
TCEd-M	NULL
and	NULL
US-1	NULL
are	NULL
also	NULL
AP-3	NULL
binding	NULL
sites	NULL
(	NULL
as	NULL
are	NULL
the	NULL
TCEd	NULL
and	NULL
TCEp	NULL
to	NULL
which	NULL
TCF-2	NULL
also	NULL
binds	NULL
)	NULL
,	NULL
TCF-2	NULL
appears	NULL
to	NULL
be	NULL
related	NULL
in	NULL
its	NULL
binding	NULL
properties	NULL
to	NULL
AP-3	NULL
.	NULL

of	NULL
kB	NULL
DNA	NULL
was	NULL
necessary	NULL
to	NULL
reach	NULL
a	NULL
(	NULL
still	NULL
incomplete	NULL
)	NULL
competition	NULL
effect	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
with	NULL
5	NULL
and	NULL
6	NULL
in	NULL
When	NULL
we	NULL
used	NULL
the	NULL
same	NULL
factor	NULL
preparation	NULL
and	NULL
a	NULL
canonical	NULL
kB	NULL
DNA	NULL
probe	NULL
in	NULL
EMSA	NULL
experiments	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
mG	NULL
ccr	NULL
``	NULL
srs	NULL
cna	NULL
o	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

The	NULL
polypeptides	NULL
of	NULL
TCF-1	NULL
:	NULL
A	NULL
kB-like	NULL
SOkD	NULL
polypeptide	NULL
is	NULL
part	NULL
of	NULL
TCF-1	NULL
.	NULL

A	NULL
.	NULL
)	NULL

Polypeptide	NULL
composition	NULL
of	NULL
TCF-1	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
a	NULL
TCF-1	NULL
preparation	NULL
(	NULL
fraction	NULL
A	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
was	NULL
fractionated	NULL
on	NULL
an	NULL
analytical	NULL
denaturing	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
followed	NULL
by	NULL
silver	NULL
staining	NULL
.	NULL

T	NULL
,	NULL
TCF-1	NULL
polypeptides	NULL
;	NULL
M	NULL
,	NULL
reference	NULL
polypeptides	NULL
.	NULL

The	NULL
TCF-1	NULL
polypeptides	NULL
of	NULL
about	NULL
SOkD	NULL
and	NULL
105kD	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
filled	NULL
square	NULL
and	NULL
circle	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
.	NULL
)	NULL

A	NULL
polypeptide	NULL
of	NULL
about	NULL
5OkD	NULL
binds	NULL
to	NULL
TCEd	NULL
DNA	NULL
after	NULL
fractionation	NULL
on	NULL
a	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
renaturation	NULL
.	NULL

A	NULL
TCF-1	NULL
preparation	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
preparative	NULL
SDS-10	NULL
%	NULL
polacrylamide	NULL
gel	NULL
.	NULL

After	NULL
the	NULL
run	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
cut	NULL
into	NULL
five	NULL
slices	NULL
which	NULL
contained	NULL
the	NULL
polypeptides	NULL
larger	NULL
than	NULL
80kD	NULL
(	NULL
slice	NULL
no	NULL
.	NULL

1	NULL
)	NULL
,	NULL
in	NULL
the	NULL
size	NULL
range	NULL
between	NULL
60	NULL
and	NULL
80kD	NULL
(	NULL
no	NULL
.	NULL

2	NULL
)	NULL
,	NULL
between	NULL
40	NULL
and	NULL
60kD	NULL
(	NULL
no	NULL
.	NULL

3	NULL
)	NULL
,	NULL
between	NULL
25	NULL
and	NULL
40kD	NULL
(	NULL
no	NULL
.	NULL

4	NULL
)	NULL
and	NULL
smaller	NULL
than	NULL
25kD	NULL
(	NULL
no	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
of	NULL
individual	NULL
slices	NULL
was	NULL
extracted	NULL
,	NULL
renatured	NULL
(	NULL
27	NULL
)	NULL
and	NULL
tested	NULL
for	NULL
TCEd	NULL
binding	NULL
in	NULL
EMSA	NULL
.	NULL

Note	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
upon	NULL
incubation	NULL
of	NULL
renatured	NULL
polypeptides	NULL
in	NULL
the	NULL
size	NULL
range	NULL
of	NULL
40-6OkD	NULL
.	NULL

C.	NULL
)	NULL
Size	NULL
determination	NULL
of	NULL
TCF-1	NULL
proteins	NULL
by	NULL
UV-crosslinking	NULL
.	NULL

A	NULL
TCF	NULL
preparation	NULL
(	NULL
fraction	NULL
B	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
bromodeoxyuridine-substituted	NULL
TCEd	NULL
probe	NULL
,	NULL
fractionated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
EMSA	NULL
gel	NULL
and	NULL
UV	NULL
irradiated	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
gel	NULL
slices	NULL
containing	NULL
the	NULL
labelled	NULL
TCF	NULL
complexes	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
10	NULL
cm	NULL
SDS-10	NULL
%	NULL
PAA	NULL
gel	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
250	NULL
V.	NULL
D.	NULL
)	NULL
and	NULL
NF-kB	NULL
share	NULL
a	NULL
similar	NULL
DNA	NULL
binding	NULL
peptide	NULL
.	NULL

Proteolytic	NULL
clipping	NULL
band	NULL
shift	NULL
assay	NULL
(	NULL
26	NULL
)	NULL
.	NULL

TCEd	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
TCF-1	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
and	NULL
5	NULL
)	NULL
or	NULL
a	NULL
kB-like	NULL
factor	NULL
from	NULL
induced	NULL
E14	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
factor	NULL
was	NULL
isolated	NULL
,	NULL
like	NULL
TCF-1	NULL
,	NULL
by	NULL
chromatography	NULL
on	NULL
a	NULL
heparin-agarose	NULL
column	NULL
,	NULL
$	NULL
300	NULL
gel	NULL
filtration	NULL
and	NULL
affinity	NULL
chromatography	NULL
on	NULL
a	NULL
DNA	NULL
column	NULL
(	NULL
25	NULL
)	NULL
containing	NULL
ligated	NULL
kB	NULL
oligonucleotides	NULL
of	NULL
Ig-kappa	NULL
enhancer	NULL
.	NULL

The	NULL
factor	NULL
probably	NULL
corresponds	NULL
to	NULL
the	NULL
50	NULL
kD	NULL
polypeptide	NULL
of	NULL
ubiquitous	NULL
NF-kB	NULL
,	NULL
the	NULL
complex	NULL
of	NULL
which	NULL
runs	NULL
slightly	NULL
faster	NULL
than	NULL
TCF-1	NULL
in	NULL
EMSA	NULL
gels	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
8-13	NULL
and	NULL
unpubl	NULL
.	NULL

results	NULL
)	NULL
.	NULL

After	NULL
complex	NULL
formation	NULL
one	NULL
unit	NULL
Staphylococcus	NULL
V8	NULL
protease	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
trypsin	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
was	NULL
added	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
20Â°C	NULL
,	NULL
followed	NULL
by	NULL
fractionation	NULL
on	NULL
a	NULL
5	NULL
%	NULL
EMSA	NULL
gel	NULL
.	NULL

Note	NULL
the	NULL
appearance	NULL
of	NULL
similar	NULL
factor	NULL
sub-complexes	NULL
after	NULL
V8	NULL
protease	NULL
cleavage	NULL
(	NULL
labelled	NULL
with	NULL
dots	NULL
beside	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
of	NULL
a	NULL
trypsin-resistant	NULL
complex	NULL
(	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
for	NULL
both	NULL
factors	NULL
.	NULL

formation	NULL
of	NULL
one	NULL
factor	NULL
fomplex	NULL
only	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
8-13	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
run	NULL
slightly	NULL
faster	NULL
than	NULL
the	NULL
TCF-1	NULL
complex	NULL
,	NULL
and	NULL
in	NULL
its	NULL
DNA	NULL
binding	NULL
properties	NULL
it	NULL
differed	NULL
from	NULL
all	NULL
three	NULL
TCF	NULL
complexes	NULL
.	NULL

We	NULL
assume	NULL
that	NULL
this	NULL
kB-like	NULL
factor	NULL
(	NULL
which	NULL
probably	NULL
corresponds	NULL
to	NULL
a	NULL
SOkD	NULL
homodimer	NULL
)	NULL
was	NULL
co-purified	NULL
on	NULL
the	NULL
TCEd	NULL
DNA	NULL
affinity	NULL
column	NULL
along	NULL
with	NULL
the	NULL
TCFs	NULL
.	NULL

TCF-1	NULL
contains	NULL
two	NULL
polypeptides	NULL
;	NULL
one	NULL
of	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
related	NULL
to	NULL
the	NULL
50kD	NULL
protein	NULL
of	NULL
NF-kB	NULL
Electrophoretic	NULL
separation	NULL
of	NULL
TCF-1	NULL
protein	NULL
(	NULL
fraction	NULL
A	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
on	NULL
denaturing	NULL
SDS-PAA	NULL
gels	NULL
yielded	NULL
three	NULL
prominent	NULL
polypeptides	NULL
of	NULL
about	NULL
50kD	NULL
,	NULL
105kD	NULL
and	NULL
170kD	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
T	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
latter	NULL
eluted	NULL
in	NULL
low	NULL
salt	NULL
buffers	NULL
(	NULL
containing	NULL
less	NULL
than	NULL
0.3M	NULL
KCI	NULL
)	NULL
from	NULL
the	NULL
TCEd	NULL
DNA	NULL
columns	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
it	NULL
is	NULL
specifically	NULL
associated	NULL
with	NULL
the	NULL
SOkD	NULL
and	NULL
105kD	NULL
polypeptides	NULL
(	NULL
which	NULL
elute	NULL
from	NULL
the	NULL
TCEd	NULL
affinity	NULL
column	NULL
in	NULL
0.6M	NULL
KCl	NULL
buffers	NULL
)	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
results	NULL
of	NULL
UV-cross	NULL
linking	NULL
experiments	NULL
in	NULL
which	NULL
TCF	NULL
proteins	NULL
(	NULL
fraction	NULL
B	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
bromodeoxyuridine-substituted	NULL
TCEd	NULL
probe	NULL
and	NULL
UV-irradiated	NULL
after	NULL
fractionation	NULL
on	NULL
EMSA	NULL
gels	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
subsequent	NULL
electrophoresis	NULL
of	NULL
cross-linked	NULL
TCEd-protein	NULL
adducts	NULL
in	NULL
denaturing	NULL
SDS-PAA	NULL
gels	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
two	NULL
major	NULL
bands	NULL
,	NULL
a	NULL
weak	NULL
band	NULL
of	NULL
about	NULL
105kD	NULL
and	NULL
a	NULL
more	NULL
prominent	NULL
one	NULL
of	NULL
5OkD	NULL
.	NULL

In	NULL
distinct	NULL
contrast	NULL
,	NULL
fractionation	NULL
of	NULL
TCF-2	NULL
and	NULL
3	NULL
adducts	NULL
resulted	NULL
in	NULL
the	NULL
appearaance	NULL
of	NULL
several	NULL
smaller	NULL
cross-linked	NULL
products	NULL
.	NULL

The	NULL
much	NULL
stronger	NULL
appearance	NULL
of	NULL
the	NULL
5SOkD	NULL
band	NULL
suggests	NULL
that	NULL
this	NULL
protein	NULL
was	NULL
bound	NULL
more	NULL
tighter	NULL
to	NULL
DNA	NULL
than	NULL
the	NULL
105kD	NULL
polypeptide	NULL
.	NULL

Results	NULL
supporting	NULL
this	NULL
assumption	NULL
were	NULL
obtained	NULL
when	NULL
TCF-1	NULL
(	NULL
fraction	NULL
A	NULL
,	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
preparative	NULL
SDS-PAA	NULL
gel	NULL
and	NULL
,	NULL
after	NULL
the	NULL
extraction	NULL
from	NULL
gel	NULL
slices	NULL
and	NULL
renaturation	NULL
(	NULL
27	NULL
)	NULL
,	NULL
used	NULL
in	NULL
EMSA	NULL
experiments	NULL
.	NULL

A	NULL
retarded	NULL
DNA-protein	NULL
complex	NULL
was	NULL
found	NULL
to	NULL
be	NULL
reconstituted	NULL
with	NULL
protein	NULL
in	NULL
the	NULL
size	NULL
range	NULL
of	NULL
40-60kD	NULL
,	NULL
but	NULL
not	NULL
of	NULL
any	NULL
other	NULL
size	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
favour	NULL
the	NULL
50kD	NULL
polypeptide	NULL
to	NULL
be	NULL
the	NULL
major	NULL
DNA	NULL
binding	NULL
component	NULL
of	NULL
TCF-1	NULL
.	NULL

The	NULL
similarity	NULL
in	NULL
size	NULL
between	NULL
the	NULL
S5SOkD	NULL
polypeptide	NULL
of	NULL
TCF-1	NULL
and	NULL
that	NULL
of	NULL
the	NULL
ubiquitous	NULL
NF-kB	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
proteins	NULL
of	NULL
both	NULL
factors	NULL
share	NULL
common	NULL
structural	NULL
properties	NULL
.	NULL

One	NULL
characteristic	NULL
feature	NULL
of	NULL
the	NULL
purified	NULL
50kD	NULL
polypeptide	NULL
of	NULL
NF-kB	NULL
is	NULL
its	NULL
cleavage	NULL
by	NULL
trypsin	NULL
to	NULL
a	NULL
large	NULL
proteolytic	NULL
peptide	NULL
fragment	NULL
(	NULL
of	NULL
about	NULL
40kD	NULL
)	NULL
which	NULL
is	NULL
still	NULL
able	NULL
to	NULL
bind	NULL
DNA	NULL
(	NULL
16	NULL
)	NULL
.	NULL

To	NULL
see	NULL
if	NULL
TCF-1	NULL
contains	NULL
a	NULL
similar	NULL
large	NULL
,	NULL
trypsin-resistant	NULL
and	NULL
DNA	NULL
binding	NULL
peptide	NULL
component	NULL
,	NULL
TCF-1	NULL
complexes	NULL
were	NULL
partially	NULL
trypsinated	NULL
and	NULL
subsequently	NULL
fractionated	NULL
on	NULL
EMSA	NULL
gels	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
a	NULL
trypsin	NULL
digest	NULL
of	NULL
a	NULL
NF-kB	NULL
factor	NULL
complex	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7D	NULL
,	NULL
trypsinisation	NULL
of	NULL
both	NULL
complexes	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
one	NULL
large	NULL
factor	NULL
complex	NULL
.	NULL

These	NULL
and	NULL
further	NULL
results	NULL
with	NULL
other	NULL
proteases	NULL
,	NULL
such	NULL
as	NULL
the	NULL
Staphylococcus	NULL
V8-protease	NULL
and	NULL
Chymotrypsin	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
and	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
indicate	NULL
that	NULL
TCF-1	NULL
shares	NULL
common	NULL
sequences	NULL
with	NULL
the	NULL
50kD	NULL
polypeptide	NULL
of	NULL
NF-kB	NULL
.	NULL

DISCUSSION	NULL
The	NULL
results	NULL
of	NULL
this	NULL
investigation	NULL
confirm	NULL
and	NULL
extend	NULL
the	NULL
data	NULL
of	NULL
earlier	NULL
published	NULL
studies	NULL
on	NULL
the	NULL
activity	NULL
and	NULL
protein	NULL
binding	NULL
of	NULL
the	NULL
TCEd	NULL
,	NULL
a	NULL
kB-like	NULL
sequence	NULL
motif	NULL
of	NULL
I1-2	NULL
enhancer	NULL
(	NULL
4	NULL
,	NULL
6-9	NULL
)	NULL
.	NULL

They	NULL
show	NULL
that	NULL
the	NULL
TCEd	NULL
is	NULL
a	NULL
functional	NULL
important	NULL
sequence	NULL
motif	NULL
of	NULL
the	NULL
murine	NULL
I1-2	NULL
enhancer	NULL
.	NULL

This	NULL
motif	NULL
alone	NULL
is	NULL
able	NULL
to	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
,	NULL
T	NULL
cell-specific	NULL
(	NULL
proto-	NULL
)	NULL
enhancer	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
results	NULL
of	NULL
this	NULL
study	NULL
show	NULL
that	NULL
in	NULL
protein	NULL
extracts	NULL
of	NULL
induced	NULL
,	NULL
1-2	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
5935	NULL
secreting	NULL
El4	NULL
T	NULL
lymphoma	NULL
cells	NULL
three	NULL
factors	NULL
with	NULL
individual	NULL
DNA	NULL
binding	NULL
properties	NULL
interact	NULL
with	NULL
the	NULL
TCEd	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
the	NULL
T	NULL
lymphocyte-specific	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
TCEd	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
concerted	NULL
action	NULL
of	NULL
several	NULL
differentially	NULL
regulated	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

The	NULL
ubiquitous	NULL
factor	NULL
NF-kB	NULL
is	NULL
also	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
TCEd	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
unpubl	NULL
.	NULL

results	NULL
;	NULL
ref	NULL
.	NULL

17	NULL
)	NULL
,	NULL
but	NULL
neither	NULL
in	NULL
crude	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
El4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
nor	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
an	NULL
efficient	NULL
binding	NULL
of	NULL
NF-kB	NULL
to	NULL
TCEd	NULL
DNA	NULL
was	NULL
detected	NULL
under	NULL
the	NULL
experimental	NULL
conditions	NULL
used	NULL
here	NULL
.	NULL

In	NULL
HeLa	NULL
cell	NULL
extracts	NULL
,	NULL
NF-kB	NULL
efficiently	NULL
bound	NULL
to	NULL
the	NULL
TCEd	NULL
derivatives	NULL
TCEd	NULL
+kBcore	NULL
and	NULL
TCEd	NULL
A-C	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
and	NULL
this	NULL
binding	NULL
is	NULL
strongly	NULL
correlated	NULL
with	NULL
the	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
both	NULL
motifs	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
induced	NULL
El4	NULL
cells	NULL
,	NULL
we	NULL
never	NULL
detected	NULL
a	NULL
clear-cut	NULL
binding	NULL
of	NULL
NF-kB	NULL
to	NULL
the	NULL
TCEd	NULL
+	NULL
kBcore	NULL
and	NULL
TCEd	NULL
A-C	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
in	NULL
these	NULL
cells	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
to	NULL
both	NULL
motifs	NULL
is	NULL
hindered	NULL
by	NULL
the	NULL
more	NULL
efficient	NULL
binding	NULL
of	NULL
TCF-1	NULL
(	NULL
and	NULL
of	NULL
other	NULL
factors	NULL
)	NULL
to	NULL
the	NULL
same	NULL
sequences	NULL
.	NULL

Like	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
TCF-1	NULL
to	NULL
numerous	NULL
TCEd-/kB-like	NULL
sequences	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
proto-enhancer	NULL
activity	NULL
of	NULL
binding	NULL
sequences	NULL
.	NULL

All	NULL
sequences	NULL
,	NULL
to	NULL
which	NULL
TCF-1	NULL
binds	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
TCEd	NULL
,	NULL
TCEd+kBcore	NULL
,	NULL
SV40	NULL
kB	NULL
and	NULL
Il-2-Ra-kB	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
are	NULL
able	NULL
to	NULL
act	NULL
as	NULL
proto-enhancers	NULL
,	NULL
whereas	NULL
all	NULL
the	NULL
other	NULL
elements	NULL
,	NULL
to	NULL
which	NULL
TCF-1	NULL
does	NULL
not	NULL
bind	NULL
,	NULL
are	NULL
unable	NULL
to	NULL
do	NULL
so	NULL
.	NULL

This	NULL
correlation	NULL
between	NULL
TCF-1	NULL
binding	NULL
and	NULL
proto-enhancer	NULL
activity	NULL
suggests	NULL
that	NULL
TCF-1	NULL
is	NULL
the	NULL
transcacting	NULL
factor	NULL
that	NULL
positively	NULL
controls	NULL
the	NULL
activity	NULL
of	NULL
TCEd	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
TCF-1	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
to	NULL
TCEd-like	NULL
motifs	NULL
does	NULL
not	NULL
exert	NULL
a	NULL
positive	NULL
influence	NULL
on	NULL
TCEd	NULL
activity	NULL
.	NULL

Instead	NULL
,	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
binding	NULL
seems	NULL
to	NULL
exert	NULL
rather	NULL
a	NULL
negative	NULL
effect	NULL
on	NULL
TCEd	NULL
DNA	NULL
.	NULL

Motifs	NULL
that	NULL
bind	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
,	NULL
but	NULL
not	NULL
TCF-1	NULL
(	NULL
such	NULL
as	NULL
the	NULL
TCEp	NULL
,	NULL
TCEd-M	NULL
and	NULL
kB+TCEdcore	NULL
motifs	NULL
:	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
are	NULL
unable	NULL
to	NULL
act	NULL
as	NULL
proto-enhancers	NULL
,	NULL
and	NULL
the	NULL
loss	NULL
of	NULL
TCF-2/TCF-3	NULL
binding	NULL
(	NULL
as	NULL
found	NULL
for	NULL
the	NULL
TCEd	NULL
+kB	NULL
core	NULL
DNA	NULL
:	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
leads	NULL
to	NULL
an	NULL
increased	NULL
proto-enhancer	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
with	NULL
TCF-1	NULL
suggests	NULL
that	NULL
TCF-1	NULL
consists	NULL
of	NULL
two	NULL
polypeptides	NULL
of	NULL
about	NULL
50kD	NULL
and	NULL
105kD	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Very	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
in	NULL
cross-linking	NULL
studies	NULL
using	NULL
nuclear	NULL
proteins	NULL
from	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
TCEd	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
I1-2	NULL
enhancer	NULL
.	NULL

The	NULL
protease	NULL
cleavage	NULL
experiments	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
indicate	NULL
that	NULL
TCF-1	NULL
and	NULL
NF-kB	NULL
share	NULL
common	NULL
DNA	NULL
binding	NULL
polypeptides	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
the	NULL
activity	NULL
of	NULL
TCEd	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
kB-like	NULL
factor	NULL
,	NULL
TCF-1	NULL
,	NULL
and	NULL
two	NULL
further	NULL
factors	NULL
,	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
,	NULL
which	NULL
seem	NULL
to	NULL
be	NULL
unrelated	NULL
to	NULL
NF-kB	NULL
.	NULL

Several	NULL
factors	NULL
other	NULL
than	NULL
NF-kB	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
kB-like	NULL
motifs	NULL
,	NULL
including	NULL
AP-3	NULL
,	NULL
MP-1	NULL
,	NULL
PRDII-BP1	NULL
,	NULL
HIV-EPI	NULL
and	NULL
Â«	NULL
A-CRYBP-1	NULL
(	NULL
32	NULL
,	NULL
34-37	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
four	NULL
factors	NULL
do	NULL
not	NULL
share	NULL
any	NULL
sequence	NULL
homology	NULL
with	NULL
NF-kB	NULL
but	NULL
belong	NULL
to	NULL
a	NULL
family	NULL
of	NULL
Zn*t*	NULL
finger	NULL
containing	NULL
DNA	NULL
binding	NULL
factors	NULL
.	NULL

Likewise	NULL
,	NULL
AP-3	NULL
differs	NULL
from	NULL
NF-kB	NULL
because	NULL
it	NULL
binds	NULL
to	NULL
several	NULL
sites	NULL
of	NULL
the	NULL
II-2	NULL
enhancer	NULL
to	NULL
which	NULL
NF-kB	NULL
does	NULL
not	NULL
bind	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
its	NULL
DNA	NULL
binding	NULL
properties	NULL
,	NULL
AP-3	NULL
appears	NULL
to	NULL
be	NULL
related	NULL
to	NULL
TCF-2	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
further	NULL
experiments	NULL
,	NULL
we	NULL
also	NULL
detected	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
bacterially	NULL
expressed	NULL
Â«	NULL
-CRYBP-1	NULL
to	NULL
the	NULL
TCEd	NULL
and	NULL
several	NULL
other	NULL
TCEd-like	NULL
sequence	NULL
motifs	NULL
(	NULL
unpubl	NULL
.	NULL

results	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
TCF-2	NULL
and	NULL
TCF-3	NULL
could	NULL
be	NULL
related	NULL
to	NULL
these	NULL
non-kB	NULL
factors	NULL
which	NULL
specifically	NULL
interact	NULL
with	NULL
kB-like	NULL
DNAs	NULL
.	NULL

5936	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

21	NULL
Finally	NULL
,	NULL
it	NULL
should	NULL
be	NULL
mentioned	NULL
that	NULL
the	NULL
TCEd	NULL
is	NULL
not	NULL
the	NULL
only	NULL
kB-like	NULL
enhancer	NULL
motif	NULL
within	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
lymphokine	NULL
genes	NULL
to	NULL
which	NULL
factors	NULL
other	NULL
than	NULL
NF-kB	NULL
bind	NULL
.	NULL

One	NULL
further	NULL
example	NULL
is	NULL
the	NULL
so-called	NULL
CK-1	NULL
(	NULL
for	NULL
cytokine	NULL
1	NULL
)	NULL
motif	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
GM-CSF	NULL
genes	NULL
which	NULL
is	NULL
bound	NULL
by	NULL
the	NULL
factor	NULL
NF-GMa	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
NF-kB	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
NF-GMa	NULL
can	NULL
not	NULL
be	NULL
induced	NULL
with	NULL
TPA	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
NF-GMa	NULL
to	NULL
CK-1	NULL
DNA	NULL
is	NULL
very	NULL
weakly	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
genuine	NULL
NF-kB	NULL
or	NULL
TCEd	NULL
DNA	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Further	NULL
examples	NULL
are	NULL
the	NULL
kB-like	NULL
motifs	NULL
of	NULL
the	NULL
murine	NULL
TNF-a	NULL
gene	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

One	NULL
of	NULL
them	NULL
,	NULL
the	NULL
site	NULL
between	NULL
the	NULL
positions	NULL
-655	NULL
and	NULL
-850	NULL
of	NULL
TNF-a	NULL
upstream	NULL
region	NULL
,	NULL
is	NULL
bound	NULL
with	NULL
high	NULL
affinity	NULL
by	NULL
proteins	NULL
not	NULL
related	NULL
to	NULL
NF-kB	NULL
(	NULL
40	NULL
)	NULL
.	NULL

These	NULL
and	NULL
further	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
kB-like	NULL
elements	NULL
within	NULL
the	NULL
transcriptional	NULL
control	NULL
regions	NULL
of	NULL
lymphokine	NULL
genes	NULL
is	NULL
controlled	NULL
by	NULL
multiple	NULL
factors	NULL
,	NULL
and	NULL
the	NULL
interplay	NULL
of	NULL
all	NULL
these	NULL
factors	NULL
seems	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
lymphokine	NULL
genes	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
For	NULL
excellent	NULL
technical	NULL
assistance	NULL
we	NULL
wish	NULL
to	NULL
thank	NULL
Hona	NULL
Pietrowski	NULL
and	NULL
Elke	NULL
Schorr	NULL
.	NULL

For	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
helpful	NULL
discussions	NULL
we	NULL
thank	NULL
K.Erb	NULL
,	NULL
W.K.Joklik	NULL
,	NULL
F.	NULL
Schaufele	NULL
and	NULL
Anneliese	NULL
Schimpl	NULL
.	NULL

We	NULL
are	NULL
very	NULL
much	NULL
indebted	NULL
to	NULL
P.	NULL
Baeuerle	NULL
for	NULL
gifts	NULL
of	NULL
NF-kB	NULL
from	NULL
human	NULL
placenta	NULL
and	NULL
the	NULL
constructs	NULL
J16	NULL
and	NULL
J32	NULL
,	NULL
to	NULL
F.	NULL
Mercurio	NULL
and	NULL
M.Karin	NULL
for	NULL
AP-3	NULL
from	NULL
HeLa	NULL
cells	NULL
and	NULL
to	NULL
K.Ozata	NULL
for	NULL
Â«	NULL
-CRYBP-1	NULL
expressed	NULL
in	NULL
insect	NULL
cells	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
of	NULL
the	NULL
Deutsche	NULL
Forschungs-gemeinschaft	NULL
(	NULL
DFG	NULL
)	NULL
,	NULL
SFB	NULL
165	NULL
,	NULL
and	NULL
the	NULL
Bundesgesundheitsamt	NULL
,	NULL
research	NULL
programme	NULL
AIDS	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Renkawitz	NULL
,	NULL
R	NULL
.	NULL

(	NULL
Ed	NULL
.	NULL
)	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Tissue	NULL
specific	NULL
gene	NULL
expression	NULL
.	NULL

VCH	NULL
Verlagsgesellschaft	NULL
Weinheim	NULL
.	NULL

2	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Taniguchi	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
401-407	NULL
.	NULL

3	NULL
.	NULL

Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
Bush	NULL
,	NULL
Morgan	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Weiss	NULL
,	NULL
A.	NULL
and	NULL
Crabtree	NULL
,	NULL
J.Exp.Med	NULL
.	NULL

165	NULL
,	NULL
395-407	NULL
.	NULL

4	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
Barthelmis	NULL
,	NULL
R.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
Schenk	NULL
,	NULL
B.	NULL
,	NULL
Zarius	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Swoboda	NULL
,	NULL
R.	NULL
,	NULL
Mercurio	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
465-473	NULL
.	NULL

5	NULL
.	NULL

Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
Shaw	NULL
,	NULL
J.P.	NULL
,	NULL
Bush	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Replogle	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Belagaje	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
(	NULL
1988	NULL
)	NULL
Mol.Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
.	NULL

6	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
Kuang	NULL
,	NULL
A.	NULL
,	NULL
Gifford	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Baltimore.D	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad.Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
8825-8829	NULL
.	NULL

7	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
and	NULL
Greene	NULL
.	NULL

W.C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
.	NULL

8	NULL
.	NULL

Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Yoneyama	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Taniguchi	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Internat	NULL
.	NULL

Immunol	NULL
.	NULL

1	NULL
,	NULL
43-49	NULL
.	NULL

9	NULL
.	NULL

Radler-Pohl	NULL
,	NULL
A.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Serfling	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
The	NULL
new	NULL
biologist	NULL
2	NULL
,	NULL
566-573	NULL
.	NULL

10	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

11	NULL
.	NULL

Baeuerie	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
The	NULL
hormonal	NULL
control	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
Cohen	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Foulkes	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
eds	NULL
)	NULL
pp.409-432	NULL
,	NULL
Elsevier/North-Holland	NULL
Biomedical	NULL
Press	NULL
.	NULL

12	NULL
.	NULL

Gosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.R	NULL
.	NULL

,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

13	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

14	NULL
.	NULL

Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

15	NULL
.	NULL

Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Dillon	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuverle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

16	NULL
.	NULL

Baeuerie	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baitimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

17	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Schreck	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.Biol.Chem	NULL
.	NULL

266	NULL
,	NULL
252-260	NULL
.	NULL

18	NULL
.	NULL

Molitor	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Walker	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Doerre	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
and	NULL
Greene	NULL
.	NULL

W.C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad.Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
10028-10032	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22.	NULL
.	NULL

Randak	NULL
,	NULL
C.	NULL
,	NULL
Brabletz.T	NULL
.	NULL

,	NULL
Hergenrother	NULL
.	NULL

M.	NULL
,	NULL
Sobotta.I	NULL
.	NULL

and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

-	NULL
Greene	NULL
.	NULL

W.C.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Ballard	NULL
,	NULL
(	NULL
1989	NULL
)	NULL
Immun	NULL
.	NULL

Today	NULL
10	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

Luthman	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Magnusson	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1295-1308.	NULL
de	NULL
Villiers	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1983	NULL
)	NULL
in	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

Techniques	NULL
in	NULL
Nucleic	NULL
Acid	NULL
Biochemistry	NULL
,	NULL
Vol.B5	NULL
,	NULL
Elsevier	NULL
,	NULL
Ireland	NULL
,	NULL
1-20	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.F	NULL
.	NULL

and	NULL
Maniatis	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Molecular	NULL
cloning	NULL
.	NULL

A	NULL
laboratory	NULL
manual	NULL
.	NULL

2	NULL
.	NULL

Edition	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Luckow	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Schiitz	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
5490	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2529-2536	NULL
.	NULL

Brabletz	NULL
,	NULL
T	NULL
.	NULL

,	NULL
Pietrowski	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Serfling	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
61-67	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.T	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

5889-5893	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
4221-4229	NULL
.	NULL

Briggs	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Kadonaga.J.T	NULL
.	NULL

,	NULL
Bell	NULL
,	NULL
S.P	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
234	NULL
,	NULL
47-52	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J	NULL
.	NULL

W.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Franza.B.R	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
827-836	NULL
.	NULL

Miyatake	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Lee	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Arai	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
2561-2568	NULL
.	NULL

Stanley	NULL
,	NULL
E.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
Sobieszezuk	NULL
,	NULL
P.	NULL
,	NULL
Gough	NULL
,	NULL
and	NULL
Dunn	NULL
,	NULL
A.R	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
2569-2573	NULL
.	NULL

Pierce	NULL
,	NULL
J	NULL
.	NULL

W.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
and	NULL
Baltimore	NULL
.	NULL

D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
1482-1486	NULL
.	NULL

Mercurio	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
.	NULL

1455-1460	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc.Natl.Acad.Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
272-278.	NULL
.	NULL

Baldwin	NULL
,	NULL
A.S.	NULL
,	NULL
LeClair	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
Singh	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Sharp	NULL
,	NULL
P	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol.Cell.Biol	NULL
.	NULL

10	NULL
,	NULL
1406-1414	NULL
.	NULL

Fan	NULL
,	NULL
C.-M.	NULL
and	NULL
Maniatis	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
29-42	NULL
.	NULL

Macekawa	NULL
,	NULL
T.	NULL
,	NULL
Sakura	NULL
,	NULL
H.	NULL
,	NULL
Sudo	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Ishii	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.Biol.Chem	NULL
.	NULL

264	NULL
,	NULL
14591-14593	NULL
.	NULL

Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Donovan	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Hamada.K	NULL
.	NULL

,	NULL
Say	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Norman	NULL
,	NULL
B.	NULL
,	NULL
Flanagan	NULL
,	NULL
J.R.	NULL
,	NULL
Ozato	NULL
,	NULL
.K	NULL
.	NULL

,	NULL
Westphal	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Piatigorsky	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell.Biol	NULL
.	NULL

10	NULL
,	NULL
3700-3708	NULL
.	NULL

Shannon	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Pell	NULL
,	NULL
L	NULL
.	NULL

M.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
Kuczek	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Occhiodoro	NULL
,	NULL
F.S	NULL
.	NULL

,	NULL
Dunn	NULL
,	NULL
S.M	NULL
.	NULL

and	NULL
Vadas	NULL
,	NULL
M.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2950-2959	NULL
.	NULL

Shakov	NULL
,	NULL
A.N	NULL
.	NULL

,	NULL
-	NULL
Collart	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.A	NULL
.	NULL

and	NULL
Jongeneel	NULL
,	NULL
C.V	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47.	NULL
.	NULL

Collart	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Baeverle	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Vassalli	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol.Cell.Biol	NULL
.	NULL

10	NULL
,	NULL
1498-1506	NULL
.	NULL

